Gefitinib (ZD1839)

目录号：S1025

Gefitinib (ZD1839) Chemical Structure

Molecular Weight(MW): 446.90

Gefitinib (ZD1839)是一种EGFR抑制剂，作用于NR6wtEGFR和NR6W细胞中的Tyr1173，Tyr992，Tyr1173和Tyr992，IC50 分别为37 nM，37nM，26 nM和57 nM。

规格 价格 库存 购买数量  
RMB 1574.78 现货
RMB 1227.69 现货
RMB 2205.98 现货
有超大折扣
大剂量询单有大折扣！

今日订购，明日送达，全国免运费！

全国免费电话：400-668-6834   |   Email：info@selleck.cn

客户购买Selleck的此次产品后发表的文献95篇：

客户使用该产品的14个实验数据：

  • c, HCC4006 lung cancer cells that have acquired a high-mesenchymal state concomitant with becoming resistant to gefitinib (red curve) exhibit increased sensitivity to GPX4 inhibition.

    Nature, 2017, 547(7664):453-457. Gefitinib (ZD1839) purchased from Selleck.

    Perturbation of EGFR by its ligand EGF and gefitinib (ZD-1839 Iressat; inhibits EGFR) produces opposite responses in the predicted EGFR target genes SOCS2 and NR2E1.

    Mol Syst Biol 2011 7, 486. Gefitinib (ZD1839) purchased from Selleck.

  • Effects of shRNA-mediated RECK depletion on EGFR signaling in MEFs. (a) Immunoblotting (IB) of the indicated proteins in wild-type MEFs transduced with the indicated shRNAs and cultured for 48 h in the presence of 0.1% dimethyl sulfoxide (DMSO; vehicle) or 1 mM gefitinib (S1025, Selleck Chemicals,Houston, TX, USA). (b) Immunoprecipitation from whole lysates of cells from panel a with an anti-phosphorylated tyrosine (pTyr) antibody. Precipitates from 500 mg protein in whole cell lysates (upper) or 20 mg protein in whole cell lysates (lower) were analyzed by IB with anti-EGFR antibody.

    Oncogene 2010 30, 737-750. Gefitinib (ZD1839) purchased from Selleck.

    (B–C) LNCaP (B) and LNCaP-AI (C) cells were transiently transfected with sPLA2-IIa(-800)-Luc (0.5 μg). The cells were then treated with Erlotinib (20 μM), Gefitinib (20 μM), Lapatinib (20 μM), CI-1033 (8 μM), LY294002 (20 lM) and Bortezomib (20 μM) without or with EGF (100 ng/ml) for 24 h. Luciferase assay was performed according to a standard protocol with Renilla luciferase as an internal control. Data are presented as the mean (±SD) of duplicate values of a representative experiment that was independently repeated for five times.

    Carcinogenesis 2010 31, 1948–1955 . Gefitinib (ZD1839) purchased from Selleck.

  • LNCaP-AI cells were starved in 1% stripped medium for 24 h. The cells were then treated with Erlotinib (20 μM), Gefitinib (20 μM), Lapatinib (20 μM), CI-1033 (8 μM), LY294002 (20 μM) and Bortezomib (20 μM) for 24 h. Cell culture medium was collected from each sample and subjected to ELISA for sPLA2-IIa. The condition medium samples were diluted 10 times for ELISA. Average of duplicate samples was converted to nanogram per milliliter against standard curve. The data represent one of five repeated experiments.

     

     

    Carcinogenesis 2010 31, 1948–1955. Gefitinib (ZD1839) purchased from Selleck.

    Suppression of EGFR signaling by Gefitinib is dose dependent and non- toxic at millimolar concentrations.Results from plaque reduction tests of Hep2 cells infected with VACV(12.5pfu/well) treated with a serial dilution of Gefitinib (1000-0.01 m) and analyzed for (A)proliferation as indicator of cytotoxicity,(B) IC50 of plaque size inhibition, (C)dose dependent inhibition of EGFR-ERK1/2signaling and VACV proteins by Western blot analysis (pEGFR detection was obtained from a different experiment with identicals ettings) and (D)dose dependent inhibition of orthopoxvirus genome replication by real-time PCR.Untreated VACV infectedcells and uninfected cells are shown as controls in the right panel.

    Antiviral Res 2010 89, 64-70. Gefitinib (ZD1839) purchased from Selleck.

  • A circular zone of EGFR activated but uninfected cells facilitate virus induced plaque development , efficiently blocked by Gefitinib. (A)Immun of luorescent staining of aplaque reduction tests with Hep2 cells 24,48,72 and 96 h after VACV infection (6.25pfu/chamber). VACV infected cells(green) were visualized by human IgG directed to orthopoxviruses (VIG) detected with a secondary FITC labelled antibody. Uninfected cells with activated EGFR signaling(red) are detected with a secondary Cy3labelled antibody. Positive cells for both , VACV and phosphorylated EGFR are shown in yellow(merge). Cellular nuclei are counterstained with DAPI. (B)Immunofluorescent staining of a plaque reduction test as described for (A) and treated with three different Gefitinib concentrations (1000 nM, 1 nM, and 0.01 nM) . The test was analyzed 96h afterVACV infection.Uninfected cells are shown as controls. Magnification100×.(For interpretation of the references to color in this figure legend , the reader is referred to the web version of the article.)

     

     

    Antiviral Res 2010 89, 64-70. Gefitinib (ZD1839) purchased from Selleck.

    Susceptibility of lung cancer cells to cytolytic activity of NK-92 cells after treatment with EGFR inhibitors. Three lung cancer cells were untreated (open circle) or treated with 10 μM erlotinib or gefitinib (black filled square or black filled triangle) for 24 hours. The lung cancer cells were cocultured with NK-92 cells at indicated effector to target ratio (E:T ratio). To determine the specificity of NKG2D-mediated cytolysis of lung cancer cells, NK-92 cells were preincubated with blocking mAb against NKG2D before the assay (gray filled square and triangle) and correspond-ing isotype mAb (open square and triangle).

    J Immunother 2011 34(4), 372-81. Gefitinib (ZD1839) purchased from Selleck.

  • Inhibition of 5-HT-induced 5-HT3A and 5-HT3AB receptor currents.

    Eur J Pharmacol, 2017, 821:21-28. Gefitinib (ZD1839) purchased from Selleck.

    The EGF-dependent increased association of PCM1 and AZI1 requires EGFR kinase activity. ZD1839 (Iressa)—EGFR tyrosine kinase inhibitor.

    Mol Biosyst 2011 7, 3223-33. Gefitinib (ZD1839) purchased from Selleck.

  • Reduction of GPER expression in HCC1806 cells after treatment with gefitinib. (A) Concentration dependence. HCC1806 cells were treated with 50-500 nM gefitinib for 48 h. GPER was detected by western blotting. (B) Time dependence. HCC1806 cells were treated with 200 nM gefitinib for 24-96 h. ap<0.05 vs. control; bp<0.001 vs. control. Mean values and SE of three independent experiments are shown. (C) Representative western blotting of concentration dependence. (D) Representative western blotting of time dependence

    Oncol Rep, 2017, 37(2):1212-1218. Gefitinib (ZD1839) purchased from Selleck.

    Inhibition of signaling pathway activation in lung tumor cell lines by kinase inhibitors. Lung tumor cells were cultured in 10% FBS until reaching ∼80% confluence and then the cells were starved in serum-free medium for overnight, followed by 4-hour treatment with the inhibitors. Cell lysates were then prepared and used for determination of the pathway activation signals by the CEER assay.

    Int J Proteomics 2011 215496. Gefitinib (ZD1839) purchased from Selleck.

  • Breast cancer cells were pretreated with 100ng/ml EGF for 15 min and then treated with the indicated concentrations of  Gefitinib for 24 hours.

     

     

    2010 Dr. Zhang of Tianjin Medical University. Gefitinib (ZD1839) purchased from Selleck.

    MTT assay result. 0-500nM Gefitinib treated with H1299, H358, H25 and HCC827 cell lines by 72h, Proliferation rate was tested.

     

     

    2010 Dr. Vicky Tin from University of Hong Kong. Gefitinib (ZD1839) purchased from Selleck.

产品安全说明书

EGFR抑制剂选择性比较

生物活性

产品描述 Gefitinib (ZD1839)是一种EGFR抑制剂，作用于NR6wtEGFR和NR6W细胞中的Tyr1173，Tyr992，Tyr1173和Tyr992，IC50 分别为37 nM，37nM，26 nM和57 nM。
特性 Gefitinib是有效的EGFR酪氨酸激酶抑制剂。
靶点
Tyr1173 (NR6W cells) [1] Tyr1173 (NR6wtEGFR cells) [1] Tyr992 (NR6wtEGFR cells) [1] Tyr992 (NR6W cells) [1]
26 nM 37 nM 37 nM 57 nM
体外研究

Gefitinib 作用于高和低表达EGFR的细胞系，包括NR6, NR6M 和 NR6W 细胞系，有效抑制EGFR上全部酪氨酸磷酸化位点。磷酸化位点 Tyr1173和Tyr992敏感性较低，需要高浓度Gefitinib才能抑制。Gefitinib作用于NR6W细胞，高效阻断PLC-γ磷酸化, IC50为27nM。NR6wtEGFR 和NR6M细胞系具有低水平PLC-γ磷酸化， IC50 分别为 43 nM和 369 nM。Gefitinib抑制AKT磷酸化，作用于低EGFR和EGFRvIII表达的细胞系， IC50 分别为220 和263nM。Gefitinib按 0.1 到 0.5μM剂量处理，显著促进而不是废除 NR6M细胞形成集落。然而, 2μM Gefitinib 完全抑制 NR6M 集落形成。Gefitinib 作用于高和低EGFR表达的细胞系，EGF 刺激72小时后，快速抑制EGFR 和ERK 磷酸化，这种作用存在剂量依赖性。[1]Gefitinib抑制 EGF驱动的未转化MCF10A 细胞生长，IC50为 20 nM。[2] Gefitinib 作用于MDA-MB-231细胞，抑制EGF信号。Gefitinib严重抑制细胞数的增多，这种作用存在剂量依赖性。 [3]
Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
KB NV6wd3ZFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVvJR|UxRTBwMEW0JO69VQ>? M4TNTVE3PTF4NEez
NIH3T3 NGDLXVRHfW6ldHnvckBCe3OjeR?= NXHoNZc{OC5{IN88US=> NH:xc3ozKGh? MXjEUXNQ NV;EdldUUW6qaXLpeIlwdiCxZjDFS2Yhe3SrbYXsZZRm\CCqdX3hckBmemKEMTDheZRweGixc4Doc5J6dGG2aX;uJJdqfGhiSVO1NEBw\iByLkCxOFQh|ryP NFHIXIEyPjR6MEK4OC=>
COS7 MWPGeY5kfGmxbjDBd5NigQ>? Moi2PVYh|ryP MnvMTY5pcWKrdHnvckBw\iCqdX3hckBLSUt{IG[2NVdHKG23dHHueEBmgHC{ZYPz[YQ> MYixO|E4QDd{Mh?=
A549 M1PBUmN6fG:2b4jpZ{BCe3OjeR?= NUXpO4Y5QTZiaB?= NW\OeW44TE2VTx?= MkXqTWM2OD1zMz61PUDPxE1? MlrONVg{OTN6MEe=
K562 NEfkUJREgXSxdH;4bYMhSXO|YYm= MV65OkBp MlLQSG1UVw>? MUPJR|UxRTlwM{[g{txO MmXwNVg{OTN6MEe=
MDA-MB-231 NEL0NI5EgXSxdH;4bYMhSXO|YYm= NXLXSXVmQTZiaB?= M13iO2ROW09? NFHyZZNKSzVyPUO2MlYyKM7:TR?= NX7mcldQOTh|MUO4NFc>
MOLT4 M4OzU2N6fG:2b4jpZ{BCe3OjeR?= M4rjclk3KGh? NV7xZXFuTE2VTx?= NVLBRVhqUUN3ME2xOU4xOiEQvF2= NXezXXUzOTh|MUO4NFc>
MCF7 MVnDfZRwfG:6aXOgRZN{[Xl? M17ifVUxKM7:TR?= MmniO|IhcA>? MlLnTWM2OD1zMj6wOUDPxE1? Mn;3NVg4PzF6MUm=
BT474 MnLHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYi3NkBp NFfVcopCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFLUOFc1KGOnbHzzJI93\XKneIDy[ZN{cW6pIFXSRoIzKHerdHigSWM2OCCxZjCwMlMh|ryP NF\IVWwyQTB{OESyOC=>
HN5 NX\rWoptT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIS1UIE4OiCq MVnBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEiQNTDj[YxteyCxdnXy[ZhxemW|c3nu[{BGT0[UIIfpeIghTUN3MDDv[kAxNjBzIN88US=> Mn;PNVkxOjh2MkS=
BA/F3 M{jJdmN6fG:2b4jpZ{BCe3OjeR?= M1\tPVczKGh? NVK1W45pS3m2b4TvfIlkcXS7IHHnZYlve3RibX;1d4UhSkFxRkOgZ4VtdHNiZYjwdoV{e2mwZzDFS2ZTKEx6NUjSJI12fGGwdDD3bZRpKEmFNUCgc4YhOC5yMUC4JO69VQ>? MXyxPVI{QTJ{OR?=
NIH3T3 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkK5O|IhcA>? MlzBS5Jwf3SqIHnubIljcXSrb36gc4YhdW:3c3WgUmlJNzOWMzDj[YxteyCneIDy[ZN{cW6pIHXyRlIh\2WwZTD3bZRpKEmFNUCgc4YhOC53NDFOwG0> NEi3[lkyQTZ4NUO3Oy=>
MCF7 MX MVHGeY5kfGmxbjDBd5NigQ>? MlzjN|AhdWmw MVnJcohq[mm2aX;uJI9nKEKFUmCg[ZhxemW|c3XkJJdqfGhiSVO1NEBw\iBzLkGg{txO M1:0T|E6QTN{OU[w
A431 MkHLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXvHZVE{OTBizszN NF;ZSHA4OiCq MoPnS2k2OD1yLkWxOEDPxE1? NYTve3ZnOTl7Nkm0OlU>
A431 NWnrR5EyU2mwYYPlJGF{e2G7 NH7Qe3MxNjFizszN NVLqb5ZwOSCq NGHNeXVKdmirYnn0bY9vKG:oIFXHSk1qdmS3Y3XkJGVITlJicHjvd5Bpd3K7bHH0bY9v M3y5flE6QTZ7NE[1
A431 NV;GO|V{U2mwYYPlJGF{e2G7 MmPwNVAxKM7:TR?= MXKxNEBucW5? NXf4eI5rWHKxbH;u[4VlKGmwaHnibZRwenliYXP0bZZqfHlib3[gSWdHNWmwZIXj[YQhTUeIUjDwbI9{eGixconsZZRqd25? MY[xPVk3QTR4NR?=
Sf9 NGO1V2RMcW6jc3WgRZN{[Xl? NVrySYoyOTBibXnu MXzEUXNQ NWrPPGdyUW6qaXLpeIlwdiCxZjDFS2ZTKGW6cILld5Nm\CCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKHKnY3XweI9zKGG3dH;wbI9{eGixconsZZRqd25id3n0bEBKSzVyIH;mJFAvODN|IN88US=> NYLvOXRtOjByNU[0NlU>
NCI-H1975 NVf3PWlkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4m2V|Uh|ryP Mk[xO|IhcA>? MoTLTWM2OD16LkK2JO69VQ>? MlzNNlAyPTF4N{C=
NCI-H1975 MoGxT4lv[XOnIFHzd4F6 M1uxTVExKM7:TR?= NEC4fZpKdmirYnn0bY9vKG:oIFXHSnIh[XW2b4Doc5NxcG:{eXzheIlwdg>? NYfucmhjOjBzNUG2O|A>
NCI-H1975 M4LLS2Z2dmO2aX;uJGF{e2G7 MlnNNVAh|ryP MoruTY5pcWKrdHnvckBw\iCHUlLCNkBifXSxcHjvd5Bpd3K7bHH0bY9v NHfpVpozODF3MU[3NC=>
NCI-H1975 MXzGeY5kfGmxbjDBd5NigQ>? NHLiV442KM7:TR?= Mn;oOFghcA>? MX3JcoR2[3Srb36gc4Yh[XCxcITvd4l{KGG|c3Xzd4VlKGG|IHHjeIl3[XSrb36gc4Yh[2G|cHHz[U0{ Mlj2NlAyPTF4N{C=
A375 NYXHNWdpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFPFbYg1QCCq NGezTnpKSzVyPUKwMlU2KM7:TR?= NHfqW4UzODNyNEWzOy=>
SMMC7721 M{nT[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkezOFghcA>? MYPJR|UxRTN|LkGyJO69VQ>? NFWxSIEzODNyNEWzOy=>
DU145 NH3KVXNEgXSxdH;4bYMhSXO|YYm= Mnq2OUBl MWPEUXNQ MmHtTWM2OD12Mj6xO{DPxE1? MWWyNFQ3PjV3NR?=
MIAPaCa2 MUXDfZRwfG:6aXOgRZN{[Xl? NVW4THBSPSCm MXfEUXNQ MVXJR|UxRTVyLk[yJO69VQ>? NUXp[ZRGOjB2Nk[1OVU>
PANC1 NH\Wb|hEgXSxdH;4bYMhSXO|YYm= MojROUBl NI\qcpJFVVOR MkLwTWM2OD12MD60NkDPxE1? MkHUNlA1PjZ3NUW=
PC9 NWrvUFdJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlXqRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDFS2ZTNWSnZnnjbYVvfCCqdX3hckBRSzliY3XscJMhf2m2aDDFR|UxKG:oIECuNFE4KM7:TR?= NYXFS2tYOjF{MEi4NFI>
PC9 M4[4VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGDxd|VCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIdzd3e2aD3y[ZNqe3SjboSgbJVu[W5iUFO5JINmdGy|IHX4dJJme3OrbnegSWdHWiCHN{S2Y2E4PTBxVEe5NG0hdXW2YX70JJdqfGhiRVO1NEBw\iB5IN88US=> NFnDbFkzOTJyOEiwNi=>
PC3 MoHTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnXWNVAh|ryP MUe3NkBp MWPEUXNQ MY\JR|UxRTdwNDFOwG0> NFzXZ5AzOTN3M{W0Oi=>
MDA-MB-468 NXviWYdET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkD1NVAxKM7:TR?= MkexOFghcA>? MlewSG1UVw>? NFnsXGtCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fS=> NE\BPZczOTR{OU[zNi=>
Plasmodium falciparum M{O1VZFJXFNicILv[oltcW6pIH\vdkBqdmirYnn0c5J{KG:oIGDsZZNud2SrdX2g[oFt[2myYYL1cUBxem:uaX\ldoF1cW:w Mn65NlE5OTdyNEW=
NCI-H1993 MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoLXO|IhcA>? NF\QfGxFVVOR NHvhS5NKSzVyPUCuNUDPxE1? MUiyNVkyPjR|Mx?=
NCI-H292 NHjRbpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3;NdFczKGh? M{TuUGROW09? NHXE[|ZKSzVyPUCuNFIh|ryP M3OzXlIyQTF4NEOz
A431 M1vJN2tqdmG|ZTDBd5NigQ>? NYTadY16OiCq NF6yeopFVVOR MYjJcohq[mm2aX;uJI9nKEWJRmKgdIhwe3Cqb4L5cIF1cW:wIHnuJGVITi2|dHnteYxifGWmIHj1cYFvKEF2M{Gge4l1cCCLQ{WwJI9nKDBwMECxJO69VQ>? MXOyNlExOTF|Mh?=
MCF7 NYexS201T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWOxNFDDqM7:Zz;tUC=> MVq0PEBp M3XqSWROW09? NWDrZm83SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNR2Y4KGOnbHzzJI93\XKneIDy[ZN{cW6pIFXHSnIh\2WwZTD3bZRpKEmFNUCgc4YhOTJwMEWg{txO MlfnNlIyOTlzM{C=
BT474 M4HubGN6fG:2b4jpZ{BCe3OjeR?= NH\QUoYyOCEQvF2= MnHEOFghcA>? MYXDfZRwfG:6aXPpeJkh[WejaX7zeEB{\XK3bT3zeIFzfmWmIHj1cYFvKEKWNEe0JINmdGy| M3WxSVIzOTN6M{C4
MCF7 MXTDfZRwfG:6aXOgRZN{[Xl? NEL3[nkyOCEQvF2= MVK0PEBp NV;U[nVOS3m2b4TvfIlkcXS7IHHnZYlve3Ric3XyeY0ue3Sjco\l[EBpfW2jbjDNR2Y4KGOnbHzzJI93\XJvZYjwdoV{e2mwZzDFdoJDOiClZXzsdy=> NETReoQzOjF|OEOwPC=>
HCC827 NV\wdlBIU2mwYYPlJGF{e2G7 NHXCeWgxNjF{NTFOwG0> NHzOT5gzPCCq M2PBTGROW09? M3HuZ2lvcGmkaYTpc44hd2ZiRVfGVkBl\WxiRUe0Ok1CPzVyIH31eIFvfCC\MUC2PEBifXSxcHjvd5Bpd3K7bHH0bY9v M4mwUFIzOzN7M{Sy
HCC827 M4TLNGtqdmG|ZTDBd5NigQ>? NF\DbXoxNjF{NTFOwG0> M2j1e|I1KGh? MlzKSG1UVw>? NHfwVIFKdmirYnn0bY9vKG:oIFXHSnIh\GWuIFW3OFYuSTd3MDDteZRidnRvbXXkbYF1\WRiRYLrJJBpd3OyaH;yfYxifGmxbh?= NEL2d4wzOjN|OUO0Ni=>
HCC827 M4Dsb2tqdmG|ZTDBd5NigQ>? MnLONE4yOjVizszN NEjtUmozPCCq MWjEUXNQ NFXEZnpKdmirYnn0bY9vKG:oIFXHSnIh\GWuIFW3OFYuSTd3MDDteZRidnRvbXXkbYF1\WRiQXv0JJBpd3OyaH;yfYxifGmxbh?= MlHRNlI{Ozl|NEK=
A431 NX;SfZF2U2mwYYPlJGF{e2G7 NUTq[2NkOTByIN88US=> MnXBN|AhdWmw NIfiWmpKdmirYnn0bY9vKG:oIFXHSnIh\GW{aY\l[EBnem:vIHj1cYFvKEF2M{GgZ4VtdCCvZX3idoFv\SCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKHCxbImtS4x2NVS7cjDwbI9{eGixconsZZRqd25id3n0bEBKSzVyIH;mJFEvODhizszN NVLw[mhLOjJ4OUi3PFI>
H460 NXvaUnlES3m2b4TvfIlkKEG|c3H5 NHLNZmg4OiCq NEDaZplKSzVyPUWuOVkh|ryP MW[yNlczPzR2OR?=
HT-29 NEniZlZEgXSxdH;4bYMhSXO|YYm= NELWVJM4OiCq M{DVb2lEPTB;Mz6zOkDPxE1? NHvHSIszOjd{N{S0PS=>
SGC7901 MVnDfZRwfG:6aXOgRZN{[Xl? NG\H[Hk4OiCq MkPUTWM2OD1zMD6yOkDPxE1? MmHzNlI4Ojd2NEm=
A498 M1fDfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkHsRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCDNEm4JINmdGy|IHX4dJJme3OrbnegSWdHWiCjbnSgV3JEKHerdHigTWM2OCCxZjC4MlYh|ryP NVzyWIY1OjJ6MUi4OFg>
Calu3 MXfDfZRwfG:6aXOgRZN{[Xl? MWexNEDPxGdxbVy= MUG3NkBp NXzoSXl1UUN3ME2xMlYh|ryP M4PXSFI{OTF4MU[4
FADU MYTDfZRwfG:6aXOgRZN{[Xl? M124WFExKM7:Zz;tUC=> MX63NkBp NHWxSHdKSzVyPUCuNFUh|ryP NXOzRoF4OjNzMU[xOlg>
HCC827 NH\lTmREgXSxdH;4bYMhSXO|YYm= MVGxNEDPxGdxbVy= Ml;0O|IhcA>? MV\JR|UxRTBwMECxOUDPxE1? MlPtNlMyOTZzNki=
PC9 NF7Eb|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MofSNVAh|rypL33M MVu3NkBp NWj2Z2RVUUN3ME2wMlAxOTRizszN MUiyN|EyPjF4OB?=
Sf9 M1HkOGtqdmG|ZTDBd5NigQ>? Mnm3NUBp MmH3SG1UVw>? MVrJcohq[mm2aX;uJI9nKGi3bXHuJGdUXC22YXfn[YQhTUeIUjDMPFM1WiCvdYThcpQh\XiycnXzd4VlKHerdHigTWM2OCCxZjCwMlAyPSEQvF2= Ml\qNlM3OTF4OUG=
16HBE14o- M{LuXGN6fG:2b4jpZ{BCe3OjeR?= NUO5VVVkOTBizszN MWS3NkBp NWDuZXB[TE2VTx?= NYjCXIc5S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hOT[KQlWxOI8uKGOnbHzzJIhiemKxcnnu[{B4cWymIIT5dIUhTUeIUjDhd5Nme3OnZDDhd{Boem:5dHigbY5pcWKrdHnvckB4cXSqIFnDOVAhd2ZiMUKuO|Eh|ryP MUeyN|Y3QDR2MR?=
NCI-H1975 NX\pblVZS3m2b4TvfIlkKEG|c3H5 MXKxNEDPxE1? MU[3NkBp Mn3WSG1UVw>? NFTjVnhEgXSxdH;4bYNqfHliYXfhbY5{fCCpZX\peIlvcWJvcnXzbZN1[W62IHj1cYFvKE6FST3INVk4PSClZXzsd{Bp[XKkb4LpcochTUeIUjDMPFU5Wi:WN{mwUUBld3WkbHWgcZV1[W62IHHzd4V{e2WmIHHzJIdzd3e2aDDpcohq[mm2aX;uJJdqfGhiSVO1NEBw\iB4LkmxO{DPxE1? NXXLSIhUOjN4Nki0OFE>
16HBE MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUXaZZF3PzJiaB?= NIWwOoZFVVOR MYXBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKDF4SFLFJINmdGy|IHX4dJJme3Orbnege4lt\CC2eYDlJGVITlJid3n0bEBKSzVyIH;mJFEvPjBzIN88US=> NI\5UnYzOzd7MkOxPC=>
16HBE NU\ufJJOTnWwY4Tpc44hSXO|YYm= NYfVOJBUOTByIN88US=> Mn7uNVUxKG2rbh?= MoTGSG1UVw>? M{\wcWlv\HWldHnvckBw\iCwaYTybYMhd3irZHWgdJJw\HWldHnvckBqdiCqdX3hckAyPkiERTDj[YxteyCneIDy[ZN{cW6pIIfpcIQhfHmyZTDFS2ZT MlvjNlM4QTJ|MUi=
A549 Mom4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYHRcngxPzJiaB?= NGC1[|BFVVOR NW[3cVBpSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEB4cWymIIT5dIUhTUeIUj;rMXJieyCmZYDlcoRmdnRiaIXtZY4hSTV2OTDj[YxteyC5aYToJGlEPTBib3[gOE43OjZizszN NGe3fWMzOzd7MkOxPC=>
SH-SY5Y MXfDfZRwfG:6aXOgRZN{[Xl? M1HFPFczKGh? NF;2T5NKSzVyPUG4MlIyKM7:TR?= MYGyN|g4OTlyOR?=
LoVo NHyz[4tMcW6jc3WgRZN{[Xl? M{HRR|IhKGh? M1nDcWROW09? NIPPSmFKdmirYnn0bY9vKG:oIFXHSnIheGixc4Doc5J6dGG2aX;uJJdqfGhiSVO1NEBw\iByLkC2NkDPxE1? NG\IU4QzOzl|MEm5OC=>
PC9 MUfLbY5ie2ViQYPzZZk> MV2yJIg> NUnPbVBFTE2VTx?= MXHJcohq[mm2aX;uJI9nKEWJRmKg[ZhwdiBzOTDk[YxmfGmxbjDhZ5RqfmG2aX7nJI12fGGwdDDwbI9{eGixconsZZRqd25iaX6gbJVu[W5iUFO5JINmdGy|IIfpeIghUUN3MDDv[kAxNjByOEeg{txO M4DVfVI{QTNyOUm0
HCC827 NUXvd4tvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHzKNYU4OiCq MkTiTWM2OD1yLkCxNkDPxE1? NYjDfoV5OjN7N{OxOlg>
A549 NHfHdXRMcW6jc3WgRZN{[Xl? M1;lSVEh|ryP NU\HPHZxOSCq MUHEUXNQ MmTFTY5pcWKrdHnvckBw\iCHR1\SJIF2fG:yaH;zdIhwenmuYYTpc44hf2m2aDDJR|UxKG:oIECuNFM6QSEQvF2= NXjTWXFlOjN7OEizOVQ>
A549 NYPj[npYTnWwY4Tpc44hSXO|YYm= MXmxJO69VQ>? NU\rXZprOSCq M1Lp[WROW09? MYnD[YxtfWyjcjD1dJRic2V? NX3wVGtIOjN7OEizOVQ>
HCC827 M{XUXmtqdmG|ZTDBd5NigQ>? MXGwMlUh|ryP NXTNOI9bOiCq M2mwRmROW09? NICzbo9KdmirYnn0bY9vKG:oIFXHSnIheGixc4Doc5J6dGG2aX;uJIlvKGenZnn0bY5q[i2{ZYPpd5RidnRiaIXtZY4hUEOFOEK3JINmdGy| MXGyN|k6OzN{OB?=
HCC827 M4jYfGZ2dmO2aX;uJGF{e2G7 M{LGfFAvPSEQvF2= MYeyJIg> NHL1ZoJFVVOR M{TENGlvcGmkaYTpc44hd2ZiYz3N[ZQheGixc4Doc5J6dGG2aX;uJIlvKGenZnn0bY5q[i2{ZYPpd5RidnRiaIXtZY4hUEOFOEK3JINmdGy| M1jLVFI{QTl|M{K4
HCC827 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV\rd5JHOTBizszN NWSze29kPzJiaB?= MYDEUXNQ MVzBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHfl[ol1cW6rYj3z[Y5{cXSrdnWgbJVu[W5iSFPDPFI4KGOnbHzzJIhiemKxcnnu[{BGT0[UIFW3OFYhfG9iQUe1NEBl\WyndHnvckB4cXSqIFnDOVAhd2ZiMD6wNFU5OSEQvF2= M{\SeVI1ODV|Nke0
A431 MUHLbY5ie2ViQYPzZZk> NU\mN5d5OTByIN88US=> M3SwNFMxKG2rbh?= MV7Jcohq[mm2aX;uJI9nKEWJRmKgbY4he2inZDDt[Y1jemGwZTD2[ZNq[2ynczD3bZRpKEmFNUCgc4YhOS5zIN88US=> NULUSYp2OjRyOUS0N|I>
BCRP-MDCK2 NV;2WIhuTnWwY4Tpc44hSXO|YYm= M3\sWVEvQCEQvF2= NF:wdXg4OiCq NV\5eHd6TE2VTx?= NWSxTZVRUW6lcnXhd4Uhd2ZicHzhd41iKG2nbXLyZY5mKGW6cILld5Nqd25ib3[gRmNTWCCneIDy[ZN{cW6pIILldI9zfGW{IHflcoUhT0[S NFnFVZQzPDF6NEKxNy=>
BCRP-MDCK2 MmjuSpVv[3Srb36gRZN{[Xl? M4L4dFEvQCEQvF2= NFH6bWo4OiCq MXvEUXNQ M1:wUHJm\HWldHnvckBw\iCybHHzcYEhdWWvYoLhcoUh\XiycnXzd4lwdiCxZjDCR3JRKGW6cILld5NqdmdicnXwc5J1\XJiZ3Xu[UBITlB? NU\Mb3ZbOjRzOESyNVM>
MDCK M3:2UWN6fG:2b4jpZ{BCe3OjeR?= MmDvO|IhcA>? NHWxOo9FVVOR NVPpNWpNT0l3ME2xMlQ2KM7:TR?= NHf4RVMzPDF6NEKxNy=>
MDCK2 NFP6O3RHfW6ldHnvckBCe3OjeR?= NX7OcVhZOS56IN88US=> NGfqWpA4OiCq MVHEUXNQ NYjkRm5wUW6qaXLpeIlwdiCxZjDoeY1idiCEQ2LQJIV5eHKnc4Pl[EBie3Onc4Pl[EBieyCKb3XjbJN1KDN|M{SyJIFk[3WvdXzheIlwdiC5aYToJGlEPTBib3[gN{4yQSEQvF2= NEHEdVYzPDF6NEKxNy=>
A431 M3PTXWN6fG:2b4jpZ{BCe3OjeR?= NEHUeYs4OiCq MYPEUXNQ MVXDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDBOFMyKGOnbHzzJIV5eHKnc4PpcochTUeIUjD3bZRpKEmFNUCgc4YhOC53NTFOwG0> NHmwRWszPDRzMUGyNy=>
Calu3 NHXEW21EgXSxdH;4bYMhSXO|YYm= M3;1RlczKGh? NFfpUmxFVVOR NVOxfGx3S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hS2GudUOgZ4VtdHNiZYjwdoV{e2mwZzDISXIzKHerdHigTWM2OCCxZjCwMlk6KM7:TR?= MmOwNlQ1OTFzMkO=
KB NFzPT2tMcW6jc3WgRZN{[Xl? MW[xNEDPxE1? NHjlcowyKGh? M4i2NGROW09? MkPLTY5pcWKrdHnvckBw\iCHR1[td5RqdXWuYYTl[EBifXSxcHjvd5Bpd3K7bHH0bY9vKG:oIFXHSnIhf2m2aDDJR|UxKG:oIECuNFI2KM7:TR?= MljvNlQ1OTFzMkO=
BEAS2B NGnpdHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{[zR|UxKM7:TR?= M3TvWVczKGh? M1ewWmROW09? NI\6RmFKSzVyPUGzMlk1KM7:TR?= MXOyOFYxPzV7MR?=
NCI-H1975 NXexUIFmTnWwY4Tpc44hSXO|YYm= MmLNNVAxKM7:TR?= MmDMNVUxKG2rbh?= NITWUVNFVVOR MYTJcoR2[3Srb36gc4YhVk9icILv[JVkfGmxbjDpckBpfW2jbjDOR2kuUDF7N{WgZ4VtdHNiaHHyZo9zcW6pIFXHSnIhVDh3OGKvWFc6OE1ibYX0ZY51 MWKyOFYxPzV7MR?=
Hela MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{nWPFI1KGh? NXTWZll6TE2VTx?= MnLKTWM2OD1{Lk[3JO69VQ>? NGrRUHAzPDd|MUK4NS=>
HepG2 NWXPPG1iT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnXqNlQhcA>? MX;EUXNQ NGW0[IJKSzVyPU[uOFIh|ryP MX[yOFc{OTJ6MR?=
Sf9 NYTC[odiU2mwYYPlJGF{e2G7 NFW1cFIyOCCvaX6= NETufnhFVVOR NH;aO5NKdmirYnn0bY9vKG:oIHH1eI9xcG:|cHjvdplt[XSrb36gc4YhemWlb33ibY5idnRiaHnzMZRi\2enZDDFS2ZTKCijbXnuc{Bi[2mmIE[0OU0yOTh4KTDlfJBz\XO|ZXSge4l1cCCLQ{WwJI9nKDBwMEKg{txO MY[yOFc{OTJ6MR?=
SW620 MmHjR5l1d3SxeHnjJGF{e2G7 NX;heotFPDhiaB?= M1PaOGROW09? NE\XbpJKSzVyPUK4MlIh|ryP NXS1UWVXOjR7MEC1PVQ>
HCC827 NXLDU4l2TnWwY4Tpc44hSXO|YYm= NVz4UnlDOC53IN88US=> NWPqcpByOiCq MYrEUXNQ MVzkc4V{KG6xdDDpcohq[mm2IHOtUYV1KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4YhSUuWIIDoc5NxcG:{eXzheIlwdg>? NUXiPHd1OjN7OUOzNlg>
HCC827 MV7GeY5kfGmxbjDBd5NigQ>? MWWwMlUh|ryP Mn7oNkBp MlrnSG1UVw>? Ml;B[I9meyCwb4SgbY5pcWKrdDDjMW1mfCCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKHB2ND:0NkBxcG:|cHjvdplt[XSrb36= MXSyN|k6OzN{OB?=
HCC827 M3HLS2N6fG:2b4jpZ{BCe3OjeR?= Ml[wNE42KM7:TR?= MVG3NkBp MoXiSG1UVw>? M3vaXohieyCwbzDjfZRwfG:6aXPpeJk> MYiyN|k6OzN{OB?=
NCI-H1975 MUfGeY5kfGmxbjDBd5NigQ>? NVTQOZRoOTBizszN MmThPEBp NIrmS2ZFVVOR M4XrN4Rw\XNibn;0JIlvcGmkaYTpJGVITlJiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJIlvKEWUSzDwbI9{eGixconsZZRqd25? NX21ZYNkOjNzMU[xOlg>
A431 M1;JWWtqdmG|ZTDBd5NigQ>? M4KwTFEh|ryP M37jO|EhcA>? M1vxVmROW09? M1LmZYhieyCwbzDpdpJmfmW{c3nicIUhcW6qaXLpeIlwdiCxZjDFS2ZTKGG3dH;wbI9{eGixconsZZRqd25? MWGyOFkxODV7NB?=
LNCaP M4H5N2Z2dmO2aX;uJGF{e2G7 MmLTNVAh|ryP MoW0Noghd3JiNDDo NIXYVXdFVVOR NH3WZ4Vld2W|IH7veEBqdmirYnn0JIF2fG:yaH;zdIhwenmuYYTpc44hd2ZiaX3teY5weHW{aX\p[YQh\myjZz30ZYdo\WRiQn34JIF{e2W|c3XkJIF{KGmwY3;ydI9z[XSrb36gc4YhYzN{UG3BWHA> NXnaSGs4OTh4NkezNVI>
H1975 M3vxbmtqdmG|ZTDBd5NigQ>? M2\1VFEh|ryP NU\4TZJnOjRiaB?= NUPINGRMTE2VTx?= Mnu2[I9meyCwb4SgbY5pcWKrdDDFS2ZTKHCqb4PwbI9zgWyjdHnvckBqdiCqdX3hckBJOTl5NTDj[YxteyCqYYLic5JqdmdiRVfGVkBNQDV6Uj;UO|kxVSCvdYThcpQ> NUjZTI1QOjR4MEe1PVE>
H1975 NF\0fJlHfW6ldHnvckBCe3OjeR?= NYHmfYlrOSEQvF2= MVmyOEBp MmDDSG1UVw>? NEW1fHpld2W|IH7veEBqdmirYnn0JGVTUyCyaH;zdIhwenmuYYTpc44hcW5iaIXtZY4hUDF7N{WgZ4VtdHNiaHHyZo9zcW6pIFXHSnIhVDh3OGKvWFc6OE1? NUH0VVNQOjR4MEe1PVE>
HCC827 Mk\rT4lv[XOnIFHzd4F6 MlO1NE4yOSEQvF2= NWr5cmNYOSCq MVzEUXNQ NWrwcYdYcGG|IH7vJIlzemW4ZYLzbYJt\SCrbnjpZol1cW:wIH;mJGVITlJiYYPz[ZN{\WRiYYOgdoVkd3[ncomgc4YhTUeIUjDheZRweGixc4Doc5J6dGG2aX;u MnvwNlQyOjR6OUi=
H1975 NYDwdZpoU2mwYYPlJGF{e2G7 NUPKTHhyOC5|MzFOwG0> MonuNkBp M1XVN2ROW09? NHfUcVFld2W|IH7veEBqdmirYnn0JGVITlJiTEi1PHIwXDd7MF2g[I92[mynIH31eIFvfCCjc4Pld5Nm\CCjczDy[YR2[3Srb36gbY4hSUuWIIDoc5NxcG:{eXzheIlwdg>? NYW1THV3OjRzMkS4PVg>
H1975 MWPLbY5ie2ViQYPzZZk> Mk\TNE4{OyEQvF2= NHjaUYwzKGh? M3O2U2ROW09? NFLoXJdld2W|IH7veEBqdmirYnn0JGVITlJiTEi1PHIwXDd7MF2g[I92[mynIH31eIFvfCCjc4Pld5Nm\CCjczDy[YR2[3Srb36gbY4hTVKNIIDoc5NxcG:{eXzheIlwdg>? NUXaPWRWOjRzMkS4PVg>
H1975 NW\qSYpnU2mwYYPlJGF{e2G7 NEnjfY8xNjN|IN88US=> NY\6PWo4OiCq NILiN3FFVVOR M4\td4Rw\XNibn;0JIlvcGmkaYSgSWdHWiCOOEW4Vk9VPzlyTTDkc5VjdGVibYX0ZY51KHCqb4PwbI9zgWyjdHnvci=> MVWyOFEzPDh7OB?=
H1975 NIHa[odMcW6jc3WgRZN{[Xl? Mn\xNE4yOjVizszN M{fVXVI1KGh? Mo\USG1UVw>? MlnF[I9meyCwb4SgbY5pcWKrdDDFS2ZTKEx6NUjSM3Q4QTCPIH31eIFvfCC\MUC2PEBifXSxcHjvd5Bpd3K7bHH0bY9v MY[yNlM{QTN2Mh?=
H1975 NU\SUpJHU2mwYYPlJGF{e2G7 MYqwMlUh|ryP NH;FemczPCCq MnzVSG1UVw>? MWTkc4V{KG6xdDDpcohq[mm2IFXHSnIhVDh3OGKvWFc6OE1ibYX0ZY51NW2nZHnheIVlKEW{azDwbI9{eGixconsZZRqd25? M3rCNVIzOzN7M{Sy
H1975 M4HON2tqdmG|ZTDBd5NigQ>? M1KwcFAvPSEQvF2= M4e4e|I1KGh? MXXEUXNQ M3rSPIRw\XNibn;0JIlvcGmkaYSgSWdHWiCOOEW4Vk9VPzlyTTDteZRidnRvbXXkbYF1\WRiQXv0JJBpd3OyaH;yfYxifGmxbh?= NWPD[HBTOjJ|M{mzOFI>
MIAPaCa2 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUnR[I1IOi53IN88US=> NG[xO|Y4OiCq Mo\oSG1UVw>? MWDoZZMhdm9iZ4Lve5RpKGmwaHnibZRqd25? M4O3U|IxPDZ4NUW1
MIAPaCa2 NX\yVmlzS3m2b4TvfIlkKEG|c3H5 MoS0NUDPxE1? MWKxNEBl MlXUSG1UVw>? MmPBbIF{KG6xIHP5eI91d3irY3n0fUBie3Onc4Pl[EBieyC|dYDwdoV{e2mxbjDv[kBkd2yxbomg[o9zdWG2aX;u MojoNlA1PjZ3NUW=
MIAPaCa2 NVnV[pc3SXCxcITvd4l{KEG|c3H5 NInFN4EyOCEQvF2= MojDNlRpKG:{IES4JIg> M{TM[GROW09? MXjkc4V{KG6xdDDpcoR2[2ViYYDvdJRwe2m| Mkn6NlA1PjZ3NUW=
MIAPaCa2 NFK3[I9CeG:ydH;zbZMhSXO|YYm= Ml;ZNlAh|ryP Mk[3NlQhcA>? MUjEUXNQ NIHtOoZld2W|IH7veEBqdmS3Y3WgZZBweHSxc3nzJIF{e2W|c3XkJIF{KGOjc4Dhd4UhOyCjY4TpeoF1cW:w M373b|IxPDZ4NUW1
EoL-1 NXnMNY5iT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlzLTWM2OD13LkG3JI5O NXLUO3dDW0GQR1XS
NCI-H720 MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWG1[4drUUN3ME2yOk46OiCwTR?= MmXNV2FPT0WU
NCI-SNU-5 NIPnTVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MW\JR|UxRTJ6LkG5JI5O NEjUcI1USU6JRWK=
EW-3 M{m4Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUDJR|UxRTR4LkC0JI5O NUGzTnZWW0GQR1XS
HCC2218 Mn\1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3PMXGlEPTB;NUCuOVkhdk1? NXvC[mdVW0GQR1XS
HuO-3N1 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEK1TpRKSzVyPUW2MlA6KG6P NFvFVIVUSU6JRWK=
DB MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnTzTWM2OD14MD65OkBvVQ>? MoLBV2FPT0WU
HSC-4 Mk\0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1nIW2lEPTB;NkGuOVMhdk1? MlLIV2FPT0WU
DOK MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MX;JR|UxRTl|Lk[yJI5O MYrTRW5ITVJ?
H9 NF33SHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1y2bWlEPTB;MUO3MlIhdk1? M{HqPXNCVkeHUh?=
NCI-H292 M1vNeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2HN[GlEPTB;MU[yMlY3KG6P M4[0R3NCVkeHUh?=
HSC-2 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmjETWM2OD1zNkWuOVchdk1? MlLJV2FPT0WU
LU-65 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml3KTWM2OD1zNk[uOlEhdk1? NXPhbpB4W0GQR1XS
BV-173 M4nsXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF[3eYJKSzVyPUG4Ok42PSCwTR?= Mo[yV2FPT0WU
LB2241-RCC MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHrjO5lKSzVyPUG5OE46OyCwTR?= NHPmb21USU6JRWK=
KG-1 NYHpTXVVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYrJR|UxRTJyND6zOEBvVQ>? MYrTRW5ITVJ?
CHL-1 NHXTd4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX;EfFI3UUN3ME2yNFgvPTFibl2= MlfrV2FPT0WU
KYSE-140 NFf5XVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUHjWWFxUUN3ME2yNFkvQTZibl2= MXrTRW5ITVJ?
DU-145 NF;oN3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYDJR|UxRTJzOT6wOEBvVQ>? MUnTRW5ITVJ?
EW-13 MonMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWHJR|UxRTJ{NT6xJI5O MWrTRW5ITVJ?
KYSE-450 NE\jT3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV\JR|UxRTJ2Nz65NkBvVQ>? NF[wVHdUSU6JRWK=
CAL-72 Mn;CS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{fMfGlEPTB;Mk[4Mlc{KG6P NF3vT3RUSU6JRWK=
MEG-01 M334cmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHj1XYFKSzVyPUK3Ok44PiCwTR?= MVjTRW5ITVJ?
HCE-T M{LFdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml;0TWM2OD1{N{muO|khdk1? MVLTRW5ITVJ?
NCI-SNU-1 NVLSbI9mT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkTqTWM2OD1{OEOuN|Ihdk1? NGXJO5RUSU6JRWK=
CAL-27 M2HjZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUfMR4s6UUN3ME2yPFkvODhibl2= NFq5VYRUSU6JRWK=
BALL-1 M3TFTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NID3OIdKSzVyPUK5O{41OiCwTR?= NIPaOotUSU6JRWK=
SBC-1 NEfm[YtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXrJR|UxRTNyNz63PUBvVQ>? MW\TRW5ITVJ?
CAL-54 NIjNeZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWrJR|UxRTNzMT6yN{BvVQ>? MYXTRW5ITVJ?
TI-73 NYXaNGsyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4nvTWlEPTB;M{GyMlc2KG6P MWHTRW5ITVJ?
P12-ICHIKAWA NGe3WXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2rPbGlEPTB;M{K4MlA3KG6P M{fkeXNCVkeHUh?=
ACHN MmnkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVLJR|UxRTN|MT60JI5O MmLKV2FPT0WU
PC-14 NH[5WGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{D1dmlEPTB;M{OzMlQyKG6P NUfqOpd1W0GQR1XS
HCC1806 MnPPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIfBVVRKSzVyPUOzO{42OSCwTR?= Ml;5V2FPT0WU
SK-MEL-24 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEXLTGlKSzVyPUOzO{45PyCwTR?= Ml\sV2FPT0WU
A4-Fuk M4LMPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3HpOGlEPTB;M{WwMlAzKG6P NVvqbYVTW0GQR1XS
ECC10 M1fyfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGDaVGxKSzVyPUO1Nk46PiCwTR?= Ml23V2FPT0WU
KASUMI-1 NETV[nFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoXiTWM2OD1|Nk[uO|Mhdk1? MXfTRW5ITVJ?
CAL-33 MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3\BWWlEPTB;M{ewMlkhdk1? MYTTRW5ITVJ?
MDA-MB-175-VII MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnvlTWM2OD1|N{iuPFghdk1? NIn2PYdUSU6JRWK=
NUGC-3 MmXGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXTIZmZ7UUN3ME20NFEvQDFibl2= MnPnV2FPT0WU
KY821 M3;TWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{XKSmlEPTB;NEC4MlU4KG6P MV;TRW5ITVJ?
CTB-1 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVjTT4MyUUN3ME20NlQvPCCwTR?= MnOyV2FPT0WU
DoTc2-4510 NGHnPYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmLHTWM2OD12NEKuNVIhdk1? NVjwXnJ3W0GQR1XS
EFO-27 NUHjNpJMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkDnTWM2OD12NUSuO|Qhdk1? MoPqV2FPT0WU
BPH-1 NV;NU2hRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHPxdHZKSzVyPUS5NU4yPiCwTR?= MYPTRW5ITVJ?
KYSE-270 M4jV[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUXJR|UxRTR7OD62OUBvVQ>? NEDtXoFUSU6JRWK=
HO-1-N-1 Ml[4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlW2TWM2OD13MEmuNlUhdk1? NVHGV3BpW0GQR1XS
SK-MEL-1 MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUTJR|UxRTVzMD65PUBvVQ>? NGPvXmdUSU6JRWK=
MOLT-13 NVfaTlFyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmXnTWM2OD13MUSuPFIhdk1? NH7hN3FUSU6JRWK=
TK10 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkHUTWM2OD13MUWuNVEhdk1? Mo\wV2FPT0WU
HN MmPSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWLJR|UxRTVzNz6zPEBvVQ>? MlXWV2FPT0WU
SCC-15 MkTOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVLidIZOUUN3ME21NlUvPjhibl2= MYXTRW5ITVJ?
NCI-H358 NVrEUXI3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mln5TWM2OD13MkeuOlYhdk1? MUnTRW5ITVJ?
KYSE-180 NGrBe4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYjUS2J6UUN3ME21N|AvPjJibl2= NY\1Rm01W0GQR1XS
NCI-H82 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYfIS2hsUUN3ME21OFAvPSCwTR?= NF74ZmlUSU6JRWK=
NB7 NEOzdo1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MULJR|UxRTV2Nj6zNkBvVQ>? MX;TRW5ITVJ?
DSH1 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX3NRlZHUUN3ME21OlYvQDhibl2= MV7TRW5ITVJ?
RS4-11 NFHicZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFLWU5dKSzVyPUW2PE42QSCwTR?= M4LRc3NCVkeHUh?=
CAN NUTGUplTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHvlTWlKSzVyPUW4NE44PiCwTR?= NVnad2VpW0GQR1XS
Ca9-22 NE\Qc3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoS4TWM2OD13OEiuOlQhdk1? M1Lnb3NCVkeHUh?=
CAL-39 NHe0TohIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUfMXW1uUUN3ME21PVYvOyCwTR?= M3nuNXNCVkeHUh?=
NCI-H1623 MlGzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYPoOWJSUUN3ME21PVkvOzZibl2= NVfZU|J[W0GQR1XS
FADU MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXHJR|UxRTZyND62PUBvVQ>? MYLTRW5ITVJ?
NB69 M3jlPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NG\Y[IhKSzVyPU[xOE4{PSCwTR?= NEnzdIdUSU6JRWK=
Ramos-2G6-4C10 MkPNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlfSTWM2OD14MkGuOFYhdk1? NVjsTmdSW0GQR1XS
LB1047-RCC MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXfHXZdzUUN3ME22NlUvOjlibl2= MUjTRW5ITVJ?
MV-4-11 MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnTyTWM2OD14MkeuO{BvVQ>? M{fwWnNCVkeHUh?=
DBTRG-05MG NHm0O3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYnJR|UxRTZ|Mj6yPEBvVQ>? MXXTRW5ITVJ?
ME-180 NGrKVZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVnJR|UxRTZ|Mj65JI5O NYnr[JB1W0GQR1XS
NBsusSR M3zHXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3jXNGlEPTB;NkS2MlUzKG6P NUPm[JF[W0GQR1XS
COR-L105 MkLLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUfJR|UxRTZ4Mj61N{BvVQ>? MoXsV2FPT0WU
ETK-1 NH7WUZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{LDO2lEPTB;Nk[yMlU6KG6P MULTRW5ITVJ?
L-363 M1;FbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFHqcIxKSzVyPU[3NU46PCCwTR?= MUnTRW5ITVJ?
LU-134-A NHXhfVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlvCTWM2OD15MUmuNFkhdk1? M{Xk[nNCVkeHUh?=
NCI-H1770 MonzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHPsNFJKSzVyPUeyNk41KG6P MYTTRW5ITVJ?
HAL-01 NYPUOWs3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIfLdppKSzVyPUezOE44OSCwTR?= NXXB[mR7W0GQR1XS
COLO-684 M3vIR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4\hV2lEPTB;N{WzMlAyKG6P NVvoPIFuW0GQR1XS
TE-6 MlP3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGGwNlZKSzVyPUe2OE4{OSCwTR?= MkXEV2FPT0WU
A431 NX3mRms2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF2xVVNKSzVyPUe4NE4xPCCwTR?= Mm\6V2FPT0WU
LU-135 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlW1TWM2OD15OEOuNFMhdk1? MXrTRW5ITVJ?
EC-GI-10 NEDmbXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkHBTWM2OD15OEiuOVIhdk1? MYLTRW5ITVJ?
TE-12 MmTXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NY\6V3JkUUN3ME24NlEvOTFibl2= NIrHcG1USU6JRWK=
LoVo MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mlv0TWM2OD16NUmuNFYhdk1? NX3aPVdwW0GQR1XS
23132-87 NIPiTHlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkX3TWM2OD16NkSuNlghdk1? NUXQWIN{W0GQR1XS
AU565 NIH3VFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2jyZWlEPTB;OE[5MlYhdk1? Mn3NV2FPT0WU
DEL Mlj5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHjlb4ZKSzVyPUi3O{43PSCwTR?= MknKV2FPT0WU
COR-L88 NGrWe4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mkj6TWM2OD16OEKuNlYhdk1? NGGxcFJUSU6JRWK=
NCI-H2126 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIK5UFFKSzVyPUi4Nk45OyCwTR?= MV\TRW5ITVJ?
CAPAN-1 NWDvNHAyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3HFW2lEPTB;OEizMlI6KG6P MYnTRW5ITVJ?
BT-474 NVfsVGl5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGfO[I5KSzVyPUmzPE4yPCCwTR?= NFPiXZZUSU6JRWK=
BHY MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3\XcWlEPTB;OUe1MlQ5KG6P MoDlV2FPT0WU
HT-3 M3qyWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVHJR|UxRTl6Mj60NUBvVQ>? MmOxV2FPT0WU
SK-NEP-1 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVjSdoJNUUN3ME25PFkvPDRibl2= M4\id3NCVkeHUh?=
MS-1 NHzVdoxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3SyW2lEPTB;OUm0MlY6KG6P NFLtUFFUSU6JRWK=
DOHH-2 MmLaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGHLN|NKSzVyPUGuNFAxOjFizszN NWrNT3FjW0GQR1XS
NCI-H1304 NHXONVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX7xV4hVUUN3ME2xMlAyPjR|IN88US=> NE\wenFUSU6JRWK=
EM-2 MkXNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXzJR|UxRTFwMEOwNVYh|ryP M3HLPXNCVkeHUh?=
MHH-PREB-1 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVfTWGJNUUN3ME2xMlA5PDVzIN88US=> M2[0VXNCVkeHUh?=
KU-19-19 NEjyWWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4Dw[GlEPTB;MT6wPFU1OSEQvF2= MlXCV2FPT0WU
NCI-H1648 M{XDe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmTjTWM2OD1zLkGwOlE3KM7:TR?= NX\DVJc2W0GQR1XS
MKN1 NHTTfnhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn3wTWM2OD1zLkKxPVg4KM7:TR?= M4TxfHNCVkeHUh?=
SNU-449 M2LIc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXHKd5pUUUN3ME2xMlIzOjB6IN88US=> NVqyfIo3W0GQR1XS
OAW-42 NVmxcIo3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M33JRWlEPTB;MT6yO|gzPSEQvF2= NVXTU|hvW0GQR1XS
769-P MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2[4PGlEPTB;MT6yO|kyQCEQvF2= NYPmWVY4W0GQR1XS
SW1088 MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGLsbpFKSzVyPUGuNlk3ODdizszN NXTuNIMyW0GQR1XS
GCIY MnXOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYr4XoViUUN3ME2xMlMxOTN{IN88US=> M3fXc3NCVkeHUh?=
CTV-1 MonNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEm3cFhKSzVyPUGuN|A5KM7:TR?= NFfxdZdUSU6JRWK=
NCI-H1092 MlHKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEfPToZKSzVyPUGuN|A5PSEQvF2= NYmyc4lJW0GQR1XS
NKM-1 M1GyRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NG\6ZphKSzVyPUGuN|I2QTdizszN MkC0V2FPT0WU
NCI-H1650 NVvxcXhVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn\wTWM2OD1zLkOzOFgzKM7:TR?= NUDxfG9qW0GQR1XS
SW954 M2K5Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M37UVmlEPTB;MT6zOFA1QCEQvF2= MnjtV2FPT0WU
SW48 MmnKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWDJR|UxRTFwM{[2NVgh|ryP Mmj3V2FPT0WU
SK-N-DZ NF2y[FFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXjZUGNNUUN3ME2xMlM3QTR5IN88US=> MYDTRW5ITVJ?
KMOE-2 Mo\SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{HvbWlEPTB;MT6zPVgyPSEQvF2= NXrre3N3W0GQR1XS
NB5 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4\D[mlEPTB;MT60NFg6PCEQvF2= MYXTRW5ITVJ?
CCRF-CEM MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXfJR|UxRTFwNEGxNUDPxE1? M1L5bnNCVkeHUh?=
RH-1 M3z4SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIDuXJhKSzVyPUGuOFEyOzZizszN NEjzXoxUSU6JRWK=
NCI-H526 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFPVOoVKSzVyPUGuOFM5OjZizszN NUjPNJZkW0GQR1XS
697 M1X3[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1HpV2lEPTB;MT60OFExPCEQvF2= M4DsTHNCVkeHUh?=
J82 MlnqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV34Tm1MUUN3ME2xMlQ2PzZ4IN88US=> M4C1SHNCVkeHUh?=
BE-13 MoXXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmTXTWM2OD1zLkWwOlcyKM7:TR?= NH7ZPYlUSU6JRWK=
SAS NUHBVWNqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1\xcWlEPTB;MT61NVYzOiEQvF2= MWHTRW5ITVJ?
SCC-25 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NU\yUJE6UUN3ME2xMlUzOzJ{IN88US=> NIf6UVFUSU6JRWK=
LAMA-84 NV;CV2t4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3zsdWlEPTB;MT61N|gyPSEQvF2= M{nWenNCVkeHUh?=
HSC-3 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUe3UVdLUUN3ME2xMlU1OzhizszN Mk\DV2FPT0WU
BT-549 NFXoZ4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1K2RWlEPTB;MT61PFc1PyEQvF2= MUTTRW5ITVJ?
ML-2 NInCRYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M13QdWlEPTB;MT62OFAzQSEQvF2= NGHjWFBUSU6JRWK=
BB30-HNC NXTxcWJxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlTmTWM2OD1zLk[4PVczKM7:TR?= MYfTRW5ITVJ?
PANC-03-27 MlK5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX;JR|UxRTFwN{CxN|kh|ryP NFPBepVUSU6JRWK=
COLO-678 Ml;aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV\JR|UxRTFwN{O0OFQh|ryP NGn3U25USU6JRWK=
NCI-H1666 NWrPS|dnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVrJR|UxRTFwN{S3NFQh|ryP M3\rS3NCVkeHUh?=
NCI-H209 NYLZTVR{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH7BXFBKSzVyPUGuO|czPjlizszN M2frbnNCVkeHUh?=
EPLC-272H NV\jWmdUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXjJR|UxRTFwOEW1OFkh|ryP M3HuUnNCVkeHUh?=
OMC-1 NV3iXlJZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXnJR|UxRTFwOUm4PFgh|ryP M3uyW3NCVkeHUh?=
HCC70 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2XqPWlEPTB;Mj6wNFgyPSEQvF2= NVrKS5JRW0GQR1XS
CAL-12T M1e1WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkW4TWM2OD1{LkCxPFYyKM7:TR?= NVn0PFJ7W0GQR1XS
TGBC24TKB NXLhNW1sT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3T4d2lEPTB;Mj6wNlk3OSEQvF2= NHfrNJdUSU6JRWK=
EKVX MkWxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVXIT4FXUUN3ME2yMlA1QTN7IN88US=> M{DBS3NCVkeHUh?=
SW1116 M2nTOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVHJR|UxRTJwME[wNFkh|ryP MYPTRW5ITVJ?
NCI-H2009 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnXhTWM2OD1{LkC2NlE1KM7:TR?= M{jKT3NCVkeHUh?=
RPMI-8866 NWjIbFVzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M33QcmlEPTB;Mj6wPFQ5OSEQvF2= MXHTRW5ITVJ?
KARPAS-45 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUDJR|UxRTJwMUK0O|kh|ryP MmGxV2FPT0WU
RXF393 NXfuV4RCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mnj0TWM2OD1{LkGzNFM3KM7:TR?= MmKyV2FPT0WU
786-0 NWPoWXlmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3\XRWlEPTB;Mj6xPFQxPiEQvF2= Mm[yV2FPT0WU
SCC-4 NEjKUGpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIr4ZYVKSzVyPUKuNlE4PzZizszN M2TiVXNCVkeHUh?=
BT-20 M1nqcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVPvdIVLUUN3ME2yMlI3PzR2IN88US=> M4DJN3NCVkeHUh?=
A498 Mn;TS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFHo[WZKSzVyPUKuNlk1OTVizszN MlLwV2FPT0WU
IGROV-1 NIXwW3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWfDR29LUUN3ME2yMlMyOjN5IN88US=> NUXGPIltW0GQR1XS
JVM-3 MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUPJR|UxRTJwM{S2OFMh|ryP NETScXNUSU6JRWK=
NCI-H2170 M4\KUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn3aTWM2OD1{LkO0O|g{KM7:TR?= NV3sfHVPW0GQR1XS
EW-18 NVjXXYc2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn;tTWM2OD1{LkO1OFcyKM7:TR?= MWTTRW5ITVJ?
KU812 M3PXRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmPGTWM2OD1{LkO2O|c6KM7:TR?= M3zYZ3NCVkeHUh?=
NY M{mxZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2n3OWlEPTB;Mj6zO|I4KM7:TR?= MoG0V2FPT0WU
HTC-C3 M{PCcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIDpbXpKSzVyPUKuOFIzPjdizszN NVfySJJXW0GQR1XS
CFPAC-1 NE\kd4hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVPXNnRwUUN3ME2yMlQ{QDZ2IN88US=> M2XMcHNCVkeHUh?=
HH NV3xZ3hwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M33UTGlEPTB;Mj60PVg2PCEQvF2= MoHBV2FPT0WU
MKN7 NFuzRndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3jQ[mlEPTB;Mj62Nlc1QCEQvF2= MkK5V2FPT0WU
TE-8 NYfxfJlLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHHSSnpKSzVyPUKuOlM3PTNizszN M32zN3NCVkeHUh?=
MC-IXC NILyUJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV3JR|UxRTJwNkS0OVMh|ryP NFm2d5lUSU6JRWK=
DMS-79 MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV3FOmFFUUN3ME2yMlY6Ojh2IN88US=> MYLTRW5ITVJ?
Detroit562 NYjFemtzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXHJR|UxRTJwNkm4OFUh|ryP M3PHSnNCVkeHUh?=
HuP-T4 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV\ZNWFjUUN3ME2yMlczQDF6IN88US=> M2r1VXNCVkeHUh?=
QIMR-WIL NVXCPFRPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVzLRXZJUUN3ME2yMlc2QTV{IN88US=> MoDXV2FPT0WU
BB65-RCC MorPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1y3VGlEPTB;Mj64NFcyOyEQvF2= NXfoSGxKW0GQR1XS
PC-3 NVvS[W5oT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXTJR|UxRTJwOEOzNVch|ryP M{XTc3NCVkeHUh?=
OVCAR-3 NWXv[nlQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXHpRnFVUUN3ME2yMlg2PTl2IN88US=> M37sPHNCVkeHUh?=
KYSE-510 M1K5U2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1vTRWlEPTB;Mj64Olc5PiEQvF2= M1fHc3NCVkeHUh?=
HC-1 NH7CSopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnPETWM2OD1{Lkm0NFEzKM7:TR?= M33MUnNCVkeHUh?=
NCI-H1693 M1nJbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVXJR|UxRTJwOUW4PVch|ryP NGrBZ5dUSU6JRWK=
DU-4475 MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVnwWXVtUUN3ME2yMlk6ODV{IN88US=> MmD2V2FPT0WU
COLO-680N M{jHcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUOzeYRrUUN3ME2zMlAxPDl3IN88US=> NFzEOVVUSU6JRWK=
MN-60 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGLN[INKSzVyPUOuNFQ6PzRizszN M33O[HNCVkeHUh?=
BCPAP NH3sRpBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnjwTWM2OD1|LkC4Nlk2KM7:TR?= MmCyV2FPT0WU
647-V M3KyRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVHJR|UxRTNwMU[yNkDPxE1? NX;Fd|VmW0GQR1XS
HT-1376 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{\BR2lEPTB;Mz6yNFUxPiEQvF2= MYnTRW5ITVJ?
NCI-H1793 M4r4NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGm3bnhKSzVyPUOuNlExQThizszN NWXlUXNCW0GQR1XS
SW1463 MlfaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2K0V2lEPTB;Mz6yOlE6OiEQvF2= MlLJV2FPT0WU
NCI-H727 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkDRTWM2OD1|LkO4OVg1KM7:TR?= M{jkPXNCVkeHUh?=
LB771-HNC MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mm\RTWM2OD1|LkO5NVI3KM7:TR?= MV7TRW5ITVJ?
D-542MG NX7YdIpET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoXNTWM2OD1|LkS0NlIzKM7:TR?= NF7ieGZUSU6JRWK=
NTERA-S-cl-D1 NFjjXVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MU\JR|UxRTNwNES5OVch|ryP M4fvcnNCVkeHUh?=
C8166 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoqyTWM2OD1|LkS2OVIyKM7:TR?= MlTqV2FPT0WU
639-V NHzBPJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX3JR|UxRTNwNUe3PVIh|ryP NGLvZ4lUSU6JRWK=
TE-1 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH73U4hKSzVyPUOuOVkyPjlizszN NXPVcWVoW0GQR1XS
OAW-28 MlKzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MljKTWM2OD1|LkW5OFI3KM7:TR?= MV;TRW5ITVJ?
SK-LU-1 NYK4WG5vT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFjVdnZKSzVyPUOuOlA3PDVizszN M2fY[HNCVkeHUh?=
CaR-1 MkLVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGjrW5pKSzVyPUOuOlExPDhizszN NVvJb4xWW0GQR1XS
A2780 NXLjNXR[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkDITWM2OD1|Lk[0NFg6KM7:TR?= NEjzdZdUSU6JRWK=
C2BBe1 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYG3S49HUUN3ME2zMlY1PDB5IN88US=> MVrTRW5ITVJ?
SK-MES-1 MlvFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFeybnpKSzVyPUOuOlQ3OTRizszN MlH4V2FPT0WU
PANC-10-05 NYjNTlRxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV\pcnUxUUN3ME2zMlczODd{IN88US=> MV3TRW5ITVJ?
J-RT3-T3-5 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVnHS|V[UUN3ME2zMlc2PDB4IN88US=> MUfTRW5ITVJ?
ES4 NXjS[XRmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{nS[mlEPTB;Mz64NlI5PiEQvF2= Mmq2V2FPT0WU
NCI-H28 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1X4XmlEPTB;Mz64Nlk3OSEQvF2= MYTTRW5ITVJ?
NCI-H1155 NEfz[WxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoTaTWM2OD1|Lki0NVU6KM7:TR?= M3zEVnNCVkeHUh?=
KURAMOCHI MkfrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVzJR|UxRTNwOE[wOVYh|ryP NVjFN2VrW0GQR1XS
NCI-H69 MnzSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4nsVmlEPTB;Mz65NFE4QCEQvF2= NX3DRXByW0GQR1XS
IST-MES1 NYnEZ|JqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGHGTJJKSzVyPUOuPVQxOjlizszN NYHUNHFDW0GQR1XS
NH-12 M2W1RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUjJR|UxRTNwOUSxPFch|ryP Mm[zV2FPT0WU
JVM-2 M3PVRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWXJR|UxRTNwOUS3OVIh|ryP NHT5NmhUSU6JRWK=
EW-16 MoHDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVfiOmxYUUN3ME2zMlk2PTd5IN88US=> M2OwSXNCVkeHUh?=
NCI-H441 M4DYTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NI\C[lJKSzVyPUOuPVcxOTRizszN NHPlUVVUSU6JRWK=
RCC10RGB NITDXpRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVL4SFl2UUN3ME20MlAyOjR4IN88US=> MWXTRW5ITVJ?
TCCSUP MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3rwUWlEPTB;ND6xNVA2KM7:TR?= MVXTRW5ITVJ?
HL-60 MkTwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUjJR|UxRTRwMUKyOFEh|ryP MU\TRW5ITVJ?
EW-11 MlfLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXvJR|UxRTRwMUOyOlEh|ryP NUH4PY9rW0GQR1XS
KARPAS-299 MmDOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M13WfGlEPTB;ND6zNVAyOyEQvF2= M33MbnNCVkeHUh?=
SNU-C2B NFzVU|ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlHRTWM2OD12LkO0Olg3KM7:TR?= MnzQV2FPT0WU
LU-139 NHm4[WlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGXzTVZKSzVyPUSuN|czPDdizszN MVzTRW5ITVJ?
HCC1937 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlPtTWM2OD12LkO3PVk{KM7:TR?= NGfvTHdUSU6JRWK=
GR-ST MmPiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NX:5e3llUUN3ME20MlQ{OThizszN NGjBTVZUSU6JRWK=
SK-OV-3 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkLkTWM2OD12LkS2NFQzKM7:TR?= MlvwV2FPT0WU
A172 NVj0d2Z7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYX2UGo3UUN3ME20MlU2PTJzIN88US=> M3fpUnNCVkeHUh?=
NB10 NEGxVnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYHJR|UxRTRwNUm3PFEh|ryP MWXTRW5ITVJ?
P30-OHK MmHoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF7re|ZKSzVyPUSuPFE6OjlizszN NYe0WIRsW0GQR1XS
KYSE-520 M1vBPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWPHfIJzUUN3ME20Mlg5ODF6IN88US=> MUjTRW5ITVJ?
KNS-62 NFvPXXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{n6ZmlEPTB;ND65NFgxPyEQvF2= MWnTRW5ITVJ?
ES1 NInwZo9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2jkXGlEPTB;ND65OlA{PSEQvF2= NFXPfHdUSU6JRWK=
KOSC-2 MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkTBTWM2OD12Lkm5PVU6KM7:TR?= MVPTRW5ITVJ?
TE-9 M{\mfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVzJR|UxRTVwMEG1NlUh|ryP NIHEc3RUSU6JRWK=
NCI-H1838 MkLES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIPXOGxKSzVyPUWuNFIxPzZizszN M3LJZnNCVkeHUh?=
KP-N-YN NGnkd5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHrFRpFKSzVyPUWuNVI2QTFizszN NHvpXGZUSU6JRWK=
ALL-PO NIm1dZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoXyTWM2OD13LkKyOVg4KM7:TR?= NULKfI9HW0GQR1XS
NOMO-1 NGPOSW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2PnbmlEPTB;NT6yN|E4PiEQvF2= NFvlTmJUSU6JRWK=
CGTH-W-1 NHPqUItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{L5UWlEPTB;NT6zPFU5PCEQvF2= MVnTRW5ITVJ?
ATN-1 M1TBPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWHxVm05UUN3ME21MlQyOTh2IN88US=> M{HLc3NCVkeHUh?=
AGS Ml7rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MY\JR|UxRTVwNEm2NVgh|ryP NIXEZ5FUSU6JRWK=
SW13 Mnj5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mmr1TWM2OD13LkWzNlY2KM7:TR?= NXHiV5E2W0GQR1XS
SW1990 NEDaZm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn7FTWM2OD13Lk[yNlg2KM7:TR?= MmfGV2FPT0WU
BFTC-905 M2LETmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGPXNnhKSzVyPUWuOlU5PzhizszN MYPTRW5ITVJ?
RMG-I MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEXBeZZKSzVyPUWuOlU6PDJizszN Mlv6V2FPT0WU
HD-MY-Z Ml7sS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoXZTWM2OD13Lk[4OVgyKM7:TR?= NGDqVFdUSU6JRWK=
HCC1187 M1q5U2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MofnTWM2OD13LkexNFMzKM7:TR?= NGjlfJJUSU6JRWK=
HCC2998 NWnkTXRTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUTJR|UxRTVwN{G4O|ch|ryP MXTTRW5ITVJ?
RT-112 NITpW5dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2rSXGlEPTB;NT65NFI1PSEQvF2= M1zVcnNCVkeHUh?=
CAKI-1 MmLkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2XxXWlEPTB;Nj6wNFk5PSEQvF2= MX3TRW5ITVJ?
HDLM-2 M1;UeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1zPWmlEPTB;Nj6wNVQ5QSEQvF2= Mkj1V2FPT0WU
TE-10 NVrwT3lyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYnJR|UxRTZwMES4N|Mh|ryP M3XKNXNCVkeHUh?=
KE-37 M1myWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1Lwb2lEPTB;Nj6wO|I2QCEQvF2= NIrUbZlUSU6JRWK=
RCM-1 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYrJR|UxRTZwMEe3NVkh|ryP M2HoUXNCVkeHUh?=
Mewo NGmxepNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoHSTWM2OD14LkGxOFg4KM7:TR?= NYXnPFZFW0GQR1XS
L-428 M2fnc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV;JR|UxRTZwMUiwN|ch|ryP Mmm5V2FPT0WU
8-MG-BA NYe2WHJ3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXPTdlVWUUN3ME22MlE6Ozd7IN88US=> NE[0UGNUSU6JRWK=
SK-MEL-28 MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVnJR|UxRTZwMkC5Olch|ryP NEHWeVlUSU6JRWK=
VA-ES-BJ MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVf2V2JOUUN3ME22MlMxPDZ{IN88US=> NHHrfFdUSU6JRWK=
CAL-120 NYjkWWI1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2\KNmlEPTB;Nj60OVE3OiEQvF2= MV7TRW5ITVJ?
GAMG NWL0d5VlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUHoVW5MUUN3ME22MlUxPjJizszN NHrueGtUSU6JRWK=
MSTO-221H Mo[5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF3ZN4dKSzVyPU[uOVEyPyEQvF2= NUHLZ3ZLW0GQR1XS
GCT Ml;QS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3T4cGlEPTB;Nj61N|M5PyEQvF2= M2XrSnNCVkeHUh?=
SH-4 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2XVVGlEPTB;Nj61PFg1PCEQvF2= MnLxV2FPT0WU
Calu-3 M{fxO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVnJR|UxRTZwNkW1Olgh|ryP NGHhWVZUSU6JRWK=
SK-HEP-1 M3rw[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUPJR|UxRTZwN{G3OVMh|ryP NFTpV2VUSU6JRWK=
PFSK-1 NGTPXVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEX0[m9KSzVyPU[uO|M1PzhizszN NHXXZpRUSU6JRWK=
NB12 Ml25S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYflSGtrUUN3ME22Mlc5PDB2IN88US=> Mo\XV2FPT0WU
A388 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoPZTWM2OD14Lki5OVIh|ryP NF7JOXNUSU6JRWK=
KLE M4L1VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{LZXGlEPTB;Nj65OlUyPiEQvF2= M{TrPHNCVkeHUh?=
TE-11 NYnJR4wzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1;ROWlEPTB;Nz6wOFk3PyEQvF2= M2jPSXNCVkeHUh?=
NCI-H2405 MnrFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXLJR|UxRTdwMEizPVMh|ryP NITCS29USU6JRWK=
OVCAR-4 M2fsc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHjmO4xKSzVyPUeuNVU{PSEQvF2= M{j3N3NCVkeHUh?=
KP-N-YS M3HTeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4LWV2lEPTB;Nz6xPFE1KM7:TR?= NGfRcmdUSU6JRWK=
NOS-1 NVW3[oVCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1ywUmlEPTB;Nz6yOVgzQCEQvF2= NETlXVlUSU6JRWK=
DMS-114 MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF\6cVRKSzVyPUeuNlk3OzFizszN NEn1VJNUSU6JRWK=
NCI-H2030 NXz3OFBQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoXzTWM2OD15LkOzOlk5KM7:TR?= NInsU4RUSU6JRWK=
HEL MlPzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mo\QTWM2OD15LkO3OVIyKM7:TR?= MXzTRW5ITVJ?
CAL-62 Ml;rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXzwXo9xUUN3ME23MlM6QDZ4IN88US=> MkjsV2FPT0WU
COLO-668 M1v5Xmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnTWTWM2OD15LkSzPVY4KM7:TR?= NYDGc3RZW0GQR1XS
SKG-IIIa M{LSVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NU\XcIM{UUN3ME23MlQ2OzhzIN88US=> MWHTRW5ITVJ?
HCC1419 MorDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{fDW2lEPTB;Nz60Olg{OyEQvF2= NWfvV|ZNW0GQR1XS
OS-RC-2 NUi3fFVxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mk[wTWM2OD15LkS5PFk1KM7:TR?= MlzYV2FPT0WU
COLO-829 Mn3oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2[4W2lEPTB;Nz62OlQ3OyEQvF2= M2Tnb3NCVkeHUh?=
NB13 M1;CV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mmj0TWM2OD15LkiyOlY4KM7:TR?= NInmfHlUSU6JRWK=
DK-MG M2fCdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NELRdG5KSzVyPUeuPFMzODFizszN M1LOU3NCVkeHUh?=
SHP-77 MlrvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2rVdWlEPTB;Nz64OlY2OyEQvF2= MmHHV2FPT0WU
NCI-H661 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXzOd|hqUUN3ME24MlA2QDZ5IN88US=> M1y2NHNCVkeHUh?=
AM-38 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHHmbnBKSzVyPUiuNVYzQCEQvF2= MmfEV2FPT0WU
VM-CUB-1 MkjnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV;JR|UxRThwMUewNlkh|ryP M{fFcHNCVkeHUh?=
KYSE-70 NGXkRZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4TGUmlEPTB;OD6xPVc3OSEQvF2= NIS2dolUSU6JRWK=
5637 MmjzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3;ibGlEPTB;OD6zNVA2PSEQvF2= MkKyV2FPT0WU
TGBC11TKB MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml3zTWM2OD16LkS2NVY1KM7:TR?= MYPTRW5ITVJ?
EGI-1 NWnKV|JoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkDLTWM2OD16Lk[wNFg5KM7:TR?= MnrPV2FPT0WU
D-392MG MoPhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVjLS4FrUUN3ME24MlY3OjF2IN88US=> NFfRVG5USU6JRWK=
A673 NYjxXHRST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2q1OmlEPTB;OD62O|YyOSEQvF2= MYrTRW5ITVJ?
COLO-792 NHKzN5dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MULJR|UxRThwN{S5OFYh|ryP NVHmOFVDW0GQR1XS
NCI-H1792 NE\xUppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWnJR|UxRThwOEi5NFMh|ryP M4jpUXNCVkeHUh?=
LS-1034 M{fWNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFTjXWdKSzVyPUiuPVQ3PTJizszN MnrSV2FPT0WU
D-566MG NV3VXYRvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYTJR|UxRTlwMEG4NUDPxE1? NYi2fWJzW0GQR1XS
NCI-H226 MmS4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoGzTWM2OD17LkC5JO69VQ>? M1\0O3NCVkeHUh?=
ChaGo-K-1 NYDSc5Y4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2n1SGlEPTB;OT6xNFU4QSEQvF2= MnfwV2FPT0WU
NCI-H2228 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWHNcGVtUUN3ME25MlEyODhzIN88US=> MWfTRW5ITVJ?
RPMI-8226 MkDsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnXSTWM2OD17LkGxN|A1KM7:TR?= NUDUZ4hRW0GQR1XS
BFTC-909 M{H3WWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2PsfmlEPTB;OT6xPFI6PyEQvF2= Mn;pV2FPT0WU
HPAF-II M1\SNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVq0U|hnUUN3ME25MlIzPTF6IN88US=> MYrTRW5ITVJ?
Capan-2 MmHQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NY\XSmRmUUN3ME25MlQxOTB7IN88US=> M2e1RnNCVkeHUh?=
IA-LM M1PLO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{nsemlEPTB;OT60NVk3PiEQvF2= NH\mcldUSU6JRWK=
KP-4 NGHjfmJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGHWS|RKSzVyPUmuOFg5OzhizszN NH20[2ZUSU6JRWK=
A101D MmHVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIPKPJpKSzVyPUmuOVE4OTlizszN NYflOJdrW0GQR1XS
EFO-21 NWn6TG1QT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3jzcmlEPTB;OT61PFc{PSEQvF2= Mnz5V2FPT0WU
C32 M1;ibWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1;5dWlEPTB;OT62N|M1KM7:TR?= MWXTRW5ITVJ?
SW837 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3fKVmlEPTB;OT64OFgzKM7:TR?= NIHJ[WlUSU6JRWK=
OCI-AML2 NELtTW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkTWTWM2OD17Lki2PVYh|ryP M3OwfnNCVkeHUh?=
NCI-H1355 NUS5T2JUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVfJR|UxRTlwOUSwPFgh|ryP M4X4SnNCVkeHUh?=
NCI-H2342 MkPRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWTJR|UxRTFyLkCxOVUh|ryP MmnDV2FPT0WU
A204 NIq5S2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{X3Z2lEPTB;MUCuNFQ3PiEQvF2= MV;TRW5ITVJ?
CAL-51 NGjaPIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4m1UmlEPTB;MUCuNFg4PyEQvF2= MoHwV2FPT0WU
HCE-4 NXnB[HU4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYXJR|UxRTFyLkGxNlIh|ryP MnL6V2FPT0WU
NCI-H810 MofYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkXqTWM2OD1zMD6xOVk4KM7:TR?= MoO5V2FPT0WU
DJM-1 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUHvZZRTUUN3ME2xNE4yPzN{IN88US=> NF\6[plUSU6JRWK=
SK-UT-1 M{\Lfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlnXTWM2OD1zMD6yOVc1KM7:TR?= NWLP[FZwW0GQR1XS
U031 M{Ttemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHfVOZBKSzVyPUGwMlI3QDZizszN M2X0XHNCVkeHUh?=
YH-13 MkHCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUjzZ4h{UUN3ME2xNE4{ODV5IN88US=> Mn;VV2FPT0WU
K5 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF7OXnpKSzVyPUGwMlM{QTVizszN NE\3XmFUSU6JRWK=
HEC-1 MmLIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWLJR|UxRTFyLkSwPFEh|ryP M3zze3NCVkeHUh?=
A2058 M4HQZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGrndpJKSzVyPUGwMlU1QTFizszN MX7TRW5ITVJ?
SW962 MlvxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M13IV2lEPTB;MUCuOlIxPCEQvF2= NXuxcWFOW0GQR1XS
VMRC-RCZ MlHDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoLDTWM2OD1zMD62O|Q6KM7:TR?= M{\XXnNCVkeHUh?=
D-336MG NEO0dWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4TKXGlEPTB;MUCuO|AxPSEQvF2= NVnnUmdMW0GQR1XS
LXF-289 MlnRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGeySnhKSzVyPUGwMlc6PjdizszN MmfnV2FPT0WU
SW900 MnTSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHj5SnlKSzVyPUGwMlgzOjhizszN MXfTRW5ITVJ?
K-562 M17vfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGPtdpFKSzVyPUGwMlg{QTVizszN NFnFXXpUSU6JRWK=
HCC38 NHvZeJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3K2[GlEPTB;MUCuPVcyPiEQvF2= MVfTRW5ITVJ?
SF-295 M4rwN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1ThbGlEPTB;MUCuPVkxOiEQvF2= NVntZZlYW0GQR1XS
LB831-BLC MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NI\YPGFKSzVyPUGxMlI2PTZizszN NGHKfZdUSU6JRWK=
FTC-133 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUfJR|UxRTFzLkOwPFEh|ryP NVWyfIQ{W0GQR1XS
HCC1954 MmfIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIXvd4ZKSzVyPUGxMlQ{PiEQvF2= Mnu5V2FPT0WU
GOTO NXezTYw3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2rDOmlEPTB;MUGuOVIxPiEQvF2= NUH3T2diW0GQR1XS
LS-411N NF:xZ5lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml;LTWM2OD1zMT62NVAyKM7:TR?= MYrTRW5ITVJ?
RPMI-7951 M2XhW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3H1SGlEPTB;MUGuOlM1QCEQvF2= NGOwUY9USU6JRWK=
NCI-H1299 NIfzTXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXOwcJBNUUN3ME2xNU43PjR5IN88US=> NH;4Z5dUSU6JRWK=
MLMA M2Lnemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1fXd2lEPTB;MUGuOlk6PyEQvF2= M4HtfXNCVkeHUh?=
MMAC-SF MmfpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MormTWM2OD1zMT63NlUzKM7:TR?= M2LpdXNCVkeHUh?=
UM-UC-3 NFfsZ4FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmTITWM2OD1zMT63OFIyKM7:TR?= NGDSV2ZUSU6JRWK=
SCC-9 MoTBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGH3cI5KSzVyPUGxMlgyPTFizszN NInPe|NUSU6JRWK=
HOS Mlu3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NX:1emVlUUN3ME2xNU45Pjh|IN88US=> M3rrOHNCVkeHUh?=
OE19 MoPnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{foNGlEPTB;MUGuPVM3PyEQvF2= NEjkd4tUSU6JRWK=
Mo-T MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXnJR|UxRTFzLkm1OFEh|ryP NYm3emo1W0GQR1XS
CAMA-1 M4rkNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUPJR|UxRTF{LkG2N|Mh|ryP Mn60V2FPT0WU
U-118-MG M4H6OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2fROWlEPTB;MUKuNlQ1OSEQvF2= NXHRdmcxW0GQR1XS
KS-1 M1TtW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFHsXZVKSzVyPUGyMlI5OzJizszN MnXOV2FPT0WU
JAR MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NELONmFKSzVyPUGyMlM{PjlizszN NGTXeFJUSU6JRWK=
ABC-1 NHTEVXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVHQOmlzUUN3ME2xNk4{PDFizszN NFniVVBUSU6JRWK=
Daoy NV3UZlVoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWnJR|UxRTF{LkS1OFIh|ryP MlHTV2FPT0WU
C3A NE\xVoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3r1SGlEPTB;MUKuOVc5PSEQvF2= MkfaV2FPT0WU
GT3TKB M3HjNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NI\qSmtKSzVyPUGyMlY{OjdizszN MmLvV2FPT0WU
DMS-273 NGn0Rm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGH4NZRKSzVyPUGyMlg3OzNizszN NULyWllFW0GQR1XS
G-361 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYHEV3BsUUN3ME2xNk46OTJ7IN88US=> M{XQUXNCVkeHUh?=
RH-18 M2nNUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGW0N5hKSzVyPUGzMlI6PjJizszN Mn\GV2FPT0WU
SN12C M4Lub2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3;OOmlEPTB;MUOuN|gxQCEQvF2= NFqwR2FUSU6JRWK=
NCI-H1993 MkLRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGPiTIxKSzVyPUGzMlQzQDVizszN M37RW3NCVkeHUh?=
LOXIMVI M4rJcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHvxRolKSzVyPUGzMlYyPTFizszN NWrpO5gyW0GQR1XS
SK-PN-DW NInLfodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkX4TWM2OD1zMz64OFI4KM7:TR?= NW\SWolMW0GQR1XS
KALS-1 NIDXb45Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXPJR|UxRTF|Lki1NlUh|ryP NF:1Z3hUSU6JRWK=
LAN-6 Mm\BS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYjJR|UxRTF2LkK1N{DPxE1? M3m0UXNCVkeHUh?=
A549 NFf1OJVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH:5b3RKSzVyPUG0MlQ4OTJizszN MYPTRW5ITVJ?
RD MnX0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MojZTWM2OD1zND60PFE{KM7:TR?= NVTCTWU5W0GQR1XS
TGBC1TKB MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkDCTWM2OD1zND62OlE2KM7:TR?= MWTTRW5ITVJ?
NCI-H630 NYDQeXYzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXPmPHNjUUN3ME2xOE46PDZ5IN88US=> MWTTRW5ITVJ?
MIA-PaCa-2 NVuwcI9yT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXrUV|dZUUN3ME2xOE46PjlizszN MkXzV2FPT0WU
NCI-H1755 M{fOUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXjJR|UxRTF2Lkm5OVMh|ryP NIG4b3pUSU6JRWK=
MOLT-4 NEXoW2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX3JR|UxRTF3LkC0PVch|ryP MoHJV2FPT0WU
CW-2 MmP1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUHJR|UxRTF3LkG0NlEh|ryP MUHTRW5ITVJ?
COLO-320-HSR NXvzb|JLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3npU2lEPTB;MUWuOVMxPyEQvF2= NYT2[ZpPW0GQR1XS
UMC-11 M3r2O2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1;sSGlEPTB;MUWuO|UzOyEQvF2= MorRV2FPT0WU
MCF7 MmLXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFPYepBKSzVyPUG1MlgyPDVizszN M1PZenNCVkeHUh?=
NCI-H23 M{mye2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUDJR|UxRTF3Lki0N|gh|ryP MUTTRW5ITVJ?
HuCCT1 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3TZ[2lEPTB;MUWuPFc1KM7:TR?= MWPTRW5ITVJ?
MPP-89 M1vJfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIHvfG1KSzVyPUG1Mlk1OTdizszN MVrTRW5ITVJ?
HT55 M{PTXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIPCS5BKSzVyPUG1Mlk1PzhizszN M{XKTnNCVkeHUh?=
no-11 MljmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3vRW2lEPTB;MUWuPVY3OyEQvF2= MkfaV2FPT0WU
GP5d MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIHrW|ZKSzVyPUG2MlIyQDdizszN NXe1PZpmW0GQR1XS
BHT-101 M1vxeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NInXbmFKSzVyPUG2MlI1OzlizszN MYXTRW5ITVJ?
M059J NEP0V49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1LSSWlEPTB;MU[uNlg1KM7:TR?= NVHpR|Z2W0GQR1XS
D-283MED MnHCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEfTWmJKSzVyPUG2MlQzODlizszN M4nMeHNCVkeHUh?=
BEN MlzvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmL2TWM2OD1zNj61NVU2KM7:TR?= NWO3OVBiW0GQR1XS
LB373-MEL-D NE\nVIZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYPJR|UxRTF4LkeyN|Ih|ryP NYLkU4NUW0GQR1XS
MEL-HO NGf2UZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{\6OmlEPTB;MU[uPFg2PCEQvF2= MnHoV2FPT0WU
GI-ME-N MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1v0ZmlEPTB;MU[uPVA{OiEQvF2= NYnldo03W0GQR1XS
RKO NWnJUYR5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmSwTWM2OD1zNz6wO|Q5KM7:TR?= NX;TWldlW0GQR1XS
MZ2-MEL M4j1emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHzyVFVKSzVyPUG3MlE{OyEQvF2= MmPDV2FPT0WU
NCI-H1573 NH3JfWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUX5ZYVvUUN3ME2xO{4zQDJ4IN88US=> MYjTRW5ITVJ?
NCI-H1581 NVXqPXFrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoDpTWM2OD1zNz60OFEyKM7:TR?= Mli4V2FPT0WU
NCI-H747 MnfYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV;IclllUUN3ME2xO{42Ojl5IN88US=> NGS4R2hUSU6JRWK=
SW1783 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkTrTWM2OD1zNz62OFE2KM7:TR?= M3rtdnNCVkeHUh?=
Calu-6 NHnkPVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUPJR|UxRTF5Lk[3PFIh|ryP NH;4PJlUSU6JRWK=
SF268 NXr1d3VbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1XrPGlEPTB;MUeuOlk3QSEQvF2= Mly5V2FPT0WU
ES8 NFjtOZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlnOTWM2OD1zNz64OVk{KM7:TR?= M3PNTnNCVkeHUh?=
KM-H2 NEOzbWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4Xre2lEPTB;MUeuPVQyOSEQvF2= NF;ocHVUSU6JRWK=
D-502MG NI\rfldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlewTWM2OD1zNz65PFA5KM7:TR?= MYnTRW5ITVJ?
HLE NGjtbFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXfJR|UxRTF6LkOxOFgh|ryP NV;w[4VQW0GQR1XS
SW982 MljES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NG\ZOI9KSzVyPUG4MlQxPzVizszN NVTkSlJ[W0GQR1XS
MDA-MB-361 M2f4O2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NX3lXlc{UUN3ME2xPE42PTh6IN88US=> NXrk[G03W0GQR1XS
NCI-H1563 NXHL[Y17T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnjVTWM2OD1zOD63NVI1KM7:TR?= MmLoV2FPT0WU
MFE-280 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHTXdpRKSzVyPUG4MlczQTNizszN NGTld41USU6JRWK=
U251 MnfXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{DpRmlEPTB;MUiuO|M1PyEQvF2= NH3YS4ZUSU6JRWK=
KNS-42 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4LSO2lEPTB;MUiuPFAyPSEQvF2= NGSyTYFUSU6JRWK=
U-266 NWi2OpJWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3S2XmlEPTB;MUiuPFY1QSEQvF2= MUPTRW5ITVJ?
OVCAR-8 NHzL[5dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH7nTm9KSzVyPUG4MlkzPzZizszN M1LmZnNCVkeHUh?=
MFH-ino MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWjG[ZJ1UUN3ME2xPE46PjZ7IN88US=> M{O0[3NCVkeHUh?=
D-263MG MmnMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4DB[WlEPTB;MUmuNFE4OiEQvF2= MUnTRW5ITVJ?
NCI-H1437 NGrTeZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVHJUpNnUUN3ME2xPU4xPDZ5IN88US=> MXTTRW5ITVJ?
NCI-H1048 MknhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF:5fYhKSzVyPUG5MlI{OjZizszN M4TLcHNCVkeHUh?=
NCI-H446 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHv6c2NKSzVyPUG5MlM2QDlizszN MlviV2FPT0WU
NCI-N87 MmTSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4q4TmlEPTB;MUmuOVk6OiEQvF2= MYjTRW5ITVJ?
WM-115 MlzzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NET1bVBKSzVyPUG5MlY4PzRizszN NUm4fnZGW0GQR1XS
HuH-7 MonyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYPJR|UxRTF7Lke0NlEh|ryP MWLTRW5ITVJ?
NCI-H650 NGrRb5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYLJR|UxRTF7Lke1NFgh|ryP NIrsT|NUSU6JRWK=
TYK-nu MlS3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHjKdpdKSzVyPUG5Mlg{PzhizszN M1W5PXNCVkeHUh?=
Becker M3zYeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGTiNI1KSzVyPUG5Mlg2PDdizszN NUHUNYg6W0GQR1XS
BB49-HNC MnHxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NW\aTFg5UUN3ME2xPU46OiEQvF2= MUjTRW5ITVJ?
HGC-27 MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWLJR|UxRTJyLkGzPVQh|ryP MoKyV2FPT0WU
SiHa MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoXtTWM2OD1{MD6zO|EzKM7:TR?= M3HTXHNCVkeHUh?=
LB2518-MEL MoTLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1rzPWlEPTB;MkCuN|c{QSEQvF2= NFjOUGxUSU6JRWK=
TE-5 M{L0OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVvJR|UxRTJyLke0PFIh|ryP MkjVV2FPT0WU
IST-SL1 NGrVbGhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFXkOYxKSzVyPUKwMlc5PzlizszN NUPOXIdkW0GQR1XS
A375 M3jzR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkHmTWM2OD1{MT6wOVY4KM7:TR?= NF\mOpNUSU6JRWK=
MC116 NIfjU2RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{nFZ2lEPTB;MkGuNFczOyEQvF2= MknoV2FPT0WU
GI-1 Mn;pS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MU\JR|UxRTJzLkG3JO69VQ>? MlPKV2FPT0WU
HOP-62 NIj4eIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGf4U4lKSzVyPUKxMlI4QDRizszN MljwV2FPT0WU
PA-1 MnzoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGny[4JKSzVyPUKxMlI4QDdizszN NYnpfJpOW0GQR1XS
HT NXezRoN[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkDhTWM2OD1{MT60N|MyKM7:TR?= MWrTRW5ITVJ?
HUTU-80 NF7rUpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUXJR|UxRTJzLkSzN|Yh|ryP M3ftWnNCVkeHUh?=
NCI-H1975 NWXiO2ZkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmjqTWM2OD1{MT60OlEh|ryP NGjiSVFUSU6JRWK=
GAK MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmPqTWM2OD1{MT60PVkh|ryP MkXOV2FPT0WU
SK-N-AS MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{fy[mlEPTB;MkGuOVYyQSEQvF2= MXnTRW5ITVJ?
OE33 M4LvSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXnJR|UxRTJzLk[wOFYh|ryP M{X0OnNCVkeHUh?=
YKG-1 NXHm[YVST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYKyTXRyUUN3ME2yNU43PTR3IN88US=> Mn7QV2FPT0WU
CAL-85 MnjxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUnyVYpCUUN3ME2yNU46OzB3IN88US=> NYfwfI9CW0GQR1XS
NCI-H2347 M2HaNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVzJR|UxRTJzLkm0Nlgh|ryP MUXTRW5ITVJ?
PANC-08-13 M1jFemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWjJR|UxRTJ{LkCxNVkh|ryP NXf0XpBFW0GQR1XS
SK-N-FI NIriXnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml3GTWM2OD1{Mj6zNFc1KM7:TR?= NFrye2tUSU6JRWK=
NEC8 NVHsU5hpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVzJR|UxRTJ{LkWwO|gh|ryP M3vwUnNCVkeHUh?=
AN3-CA MnWwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEPQfYRKSzVyPUKyMlYxQDRizszN NEDhVWVUSU6JRWK=
HuO9 M4L2Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4e2TWlEPTB;MkKuO|M6PiEQvF2= MX;TRW5ITVJ?
COLO-800 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGjC[XlKSzVyPUKyMlc3PTNizszN MYPTRW5ITVJ?
HT-29 M1y4VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2rhWWlEPTB;MkKuPFgzOyEQvF2= Ml30V2FPT0WU
OC-314 MlfhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVuzcZR5UUN3ME2yNk45QDR3IN88US=> MWTTRW5ITVJ?
G-401 NGHRbHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWPsR5BUUUN3ME2yN{4xPDZ{IN88US=> MkHiV2FPT0WU
Saos-2 NFKwPIdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnXFTWM2OD1{Mz61NVgzKM7:TR?= NHLtcoVUSU6JRWK=
UACC-62 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH3SWVZKSzVyPUKzMlU5OzNizszN MnH5V2FPT0WU
D-247MG NGfYbXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml\2TWM2OD1{Mz63PVM6KM7:TR?= MYfTRW5ITVJ?
COLO-741 NYXJcFJsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MofUTWM2OD1{Mz65OVY2KM7:TR?= NIHPbmRUSU6JRWK=
ES3 Mnf2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoXVTWM2OD1{ND6wNFI{KM7:TR?= NEG0b3VUSU6JRWK=
LNCaP-Clone-FGC NVT2RVdvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2Did2lEPTB;MkSuNFIyOSEQvF2= MmrvV2FPT0WU
SW1710 M{O2Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUPJR|UxRTJ2LkG1NFYh|ryP MYLTRW5ITVJ?
LU-99A MoD0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGXoOpNKSzVyPUK0MlE5PDFizszN NX7JW5RoW0GQR1XS
HOP-92 MlTCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV36R5RzUUN3ME2yOE44OjVizszN MnTIV2FPT0WU
LS-123 NXvYVZJUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1LVRWlEPTB;MkSuPVYyPCEQvF2= M2DCe3NCVkeHUh?=
T84 NU[2PXMxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NE\tTFNKSzVyPUK0Mlk4PjVizszN NYjadmtxW0GQR1XS
HCT-116 NXvnS5c4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml3QTWM2OD1{NT60NVg3KM7:TR?= NFvsXm5USU6JRWK=
M14 NVrQWIpsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4Sx[mlEPTB;MkWuOFQ1PyEQvF2= NHTSd4xUSU6JRWK=
OCUB-M M13Hd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4LHN2lEPTB;MkWuOFQ2PiEQvF2= NG[xdoJUSU6JRWK=
MKN45 MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYrTclN1UUN3ME2yOU43OzF3IN88US=> NHzaeWRUSU6JRWK=
LCLC-97TM1 MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{n1eGlEPTB;MkWuO|I5PSEQvF2= MYDTRW5ITVJ?
RVH-421 NWO1[JlQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYfPeYpiUUN3ME2yOU45OTZzIN88US=> MUTTRW5ITVJ?
NKS-81-FD MlfqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MofETWM2OD1{NT65NFIyKM7:TR?= MXzTRW5ITVJ?
NCI-H596 M1m5Tmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml7RTWM2OD1{Nj6wOFg4KM7:TR?= NW\DTYdqW0GQR1XS
GB-1 NETUNIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX\JR|UxRTJ4LkG4O|kh|ryP M2G0PXNCVkeHUh?=
ZR-75-30 MmHhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4i0WGlEPTB;Mk[uNlI6PyEQvF2= M4HmfXNCVkeHUh?=
U-2-OS NVTXVXVHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXi1PWtHUUN3ME2yOk4{PzV5IN88US=> NGLN[4NUSU6JRWK=
HuP-T3 NGXOTIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFWzOFJKSzVyPUK2MlYyODJizszN MoLRV2FPT0WU
MOLT-16 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUPJR|UxRTJ4Lk[xOlYh|ryP Mkj2V2FPT0WU
U-87-MG M1v5c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUOzeoN1UUN3ME2yOk44PDN6IN88US=> NWHSUFAzW0GQR1XS
8505C M2DvZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXHJR|UxRTJ4LkmxNlYh|ryP NXXpfnlCW0GQR1XS
SK-MEL-3 NHrIeG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{LXfWlEPTB;Mk[uPVgzQCEQvF2= NUK0NIRUW0GQR1XS
COLO-824 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnXsTWM2OD1{Nz6yNVk2KM7:TR?= M2f2U3NCVkeHUh?=
EW-1 NFnMS4hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYPJR|UxRTJ5LkO1OVQh|ryP M13VOnNCVkeHUh?=
UACC-257 MlfkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVX1blR3UUN3ME2yO{4{QDB2IN88US=> NWLscXcxW0GQR1XS
Hs-578-T NIfV[lNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{LYUWlEPTB;MkeuOVI6QSEQvF2= NVnrcZdFW0GQR1XS
UACC-893 NULw[VFzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmH3TWM2OD1{Nz62OlMyKM7:TR?= NGT6TopUSU6JRWK=
MHH-NB-11 NWTHU|VzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M33ZXmlEPTB;MkeuPFAxPyEQvF2= NVrCWpNHW0GQR1XS
KYSE-410 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVyyUYFvUUN3ME2yPE4zPzd7IN88US=> Ml7yV2FPT0WU
SF126 MmPUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUnFVlVuUUN3ME2yPE44PDN3IN88US=> NHnuXpVUSU6JRWK=
HT-144 MoS4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV\HfYFlUUN3ME2yPU4{OzZ{IN88US=> MonYV2FPT0WU
SW1573 MkfoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXHpcGlvUUN3ME2yPU4{PTB7IN88US=> MUfTRW5ITVJ?
SW620 M1fNSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NETUTJRKSzVyPUK5MlM3PDFizszN MlrjV2FPT0WU
SCH NFTSS5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYrJR|UxRTJ7Lki4N|Eh|ryP MkHqV2FPT0WU
EW-22 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1jrTWlEPTB;M{CuNVk3QSEQvF2= MoXnV2FPT0WU
H4 M1fMU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFXSVGxKSzVyPUOwMlQ3PTRizszN NUD0fZE1W0GQR1XS
CAS-1 NFnWe|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn34TWM2OD1|MD63PFU6KM7:TR?= M2\zSXNCVkeHUh?=
MG-63 NF3wOWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV;JR|UxRTNyLki0O|gh|ryP MWLTRW5ITVJ?
MDA-MB-415 NEXLbphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3fPVmlEPTB;M{GuNVc2OyEQvF2= MoDUV2FPT0WU
NCI-H1395 NF;BR2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MULJR|UxRTNzLkKzNlgh|ryP MUPTRW5ITVJ?
Ca-Ski MojrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4r1O2lEPTB;M{GuN|E4PyEQvF2= NIjTOVlUSU6JRWK=
BxPC-3 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEnZbINKSzVyPUOxMlM4OjlizszN MXfTRW5ITVJ?
A3-KAW NInIR2JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4\CV2lEPTB;M{GuOFQ4OSEQvF2= MUjTRW5ITVJ?
T-24 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnTPTWM2OD1|MT63N|YzKM7:TR?= NWW0TnMzW0GQR1XS
NCI-H2029 M2HCOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVPJR|UxRTNzLke3OlUh|ryP NXHCTpNzW0GQR1XS
YAPC MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFHDVZZKSzVyPUOyMlA1ODdizszN NXG5U3lTW0GQR1XS
SK-MEL-2 NIG2Rm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2HNbmlEPTB;M{KuNFUzKM7:TR?= MYHTRW5ITVJ?
LS-513 MojJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmHOTWM2OD1|Mj6xNVg4KM7:TR?= MmrSV2FPT0WU
AsPC-1 M4DGNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIKxO5RKSzVyPUOyMlM3ODVizszN M2O2NXNCVkeHUh?=
KYSE-150 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlzyTWM2OD1|Mj6zO|c{KM7:TR?= NXPHRZBuW0GQR1XS
NCI-H520 MnK0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH:2eVdKSzVyPUOyMlQ1QDJizszN M2LKS3NCVkeHUh?=
JEG-3 M3PuOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHHOWmRKSzVyPUOzMlA6PzFizszN MlvUV2FPT0WU
GMS-10 M3;WSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIHXU4xKSzVyPUOzMlMxODRizszN NX7ie5NzW0GQR1XS
HT-1080 NVG1fZlVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYLJR|UxRTN|LkO5JO69VQ>? MoTOV2FPT0WU
NCI-H1651 MkT1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEfUVlVKSzVyPUOzMlM6PiEQvF2= NGT5VGlUSU6JRWK=
NCI-H2122 NWrQR2ZmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUTjd2V[UUN3ME2zN{42PTd2IN88US=> MlXlV2FPT0WU
ES5 Ml\ES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmnWTWM2OD1|Mz63NlkzKM7:TR?= NX\le4FZW0GQR1XS
8305C MnjxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2myUmlEPTB;M{OuPVk{PyEQvF2= M4rmXnNCVkeHUh?=
KM12 M2jBSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkX4TWM2OD1|ND6wOFc5KM7:TR?= MmjMV2FPT0WU
HCT-15 NELIc5lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH;x[XBKSzVyPUO0MlEzPyEQvF2= M3XKVXNCVkeHUh?=
OVCAR-5 M1PEdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIHjZWVKSzVyPUO0MlIyQDJizszN MnvKV2FPT0WU
NCI-H2291 MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGrY[VFKSzVyPUO0MlI1PzJizszN NGPEdWpUSU6JRWK=
CP50-MEL-B NWTneYU1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYTJR|UxRTN2Lk[1PVIh|ryP NWLxfpVFW0GQR1XS
C-33-A NFy3TXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1XOZWlEPTB;M{SuOlg2PyEQvF2= NGjx[JBUSU6JRWK=
NCI-H2452 MmP2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWHJR|UxRTN2Lke4PFIh|ryP MkfEV2FPT0WU
MDA-MB-157 MmXOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXz3VG1[UUN3ME2zOE45OTl|IN88US=> MnXTV2FPT0WU
LN-405 MnfRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlrtTWM2OD1|NT60N|A5KM7:TR?= MUTTRW5ITVJ?
MDA-MB-231 NWLac2tHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH3u[IlKSzVyPUO1MlUxPTRizszN MVrTRW5ITVJ?
EW-24 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIrKPZBKSzVyPUO1MlY{OzVizszN MX7TRW5ITVJ?
MKN28 M3ThPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVm0[WV3UUN3ME2zOU45OjN4IN88US=> MWrTRW5ITVJ?
KINGS-1 NEjnV3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHf4eXVKSzVyPUO1Mlg1OzRizszN NYW5fZRqW0GQR1XS
LC-2-ad MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MV;JR|UxRTN4Lk[5PUDPxE1? MV\TRW5ITVJ?
IGR-1 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmSyTWM2OD1|Nj63NFc2KM7:TR?= NX7hTXdDW0GQR1XS
SW626 Ml;2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MW\JR|UxRTN5LkC0NVch|ryP M4C3WHNCVkeHUh?=
ONS-76 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUjJR|UxRTN5LkGzNFkh|ryP M3;te3NCVkeHUh?=
T98G NXXhfVFlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUTJR|UxRTN5Lki2N|Uh|ryP MULTRW5ITVJ?
NB14 MnvWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYHJR|UxRTN6LkS1OFQh|ryP NXvJPFNwW0GQR1XS
D-423MG M37RZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1PFTmlEPTB;M{iuOFg3QSEQvF2= MUnTRW5ITVJ?
NCI-H510A MoHyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUXF[|lRUUN3ME2zPE43PDVzIN88US=> NFy0[29USU6JRWK=
NMC-G1 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHfBV4JKSzVyPUO4MlczOjJizszN MmniV2FPT0WU
SW948 MnXkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NI\M[JdKSzVyPUO4Mlg6PDlizszN MV\TRW5ITVJ?
MFM-223 NVnST2NyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlPmTWM2OD1|OD65OFMyKM7:TR?= NYDjS5B7W0GQR1XS
PAN1 NYfsPHJtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnjoTWM2OD1|OD65PVE6KM7:TR?= NUPTeVljW0GQR1XS
MZ7-mel NWG4ZnptT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3nUNWlEPTB;M{muNVE6QSEQvF2= MUHTRW5ITVJ?
COLO-679 MkXyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NG[4fIZKSzVyPUO5Mlk4ODhizszN M{TmZnNCVkeHUh?=
SW872 NV3XUlBUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYHJR|UxRTRyLkKwN|Eh|ryP NETNVG9USU6JRWK=
HT-1197 NVPv[XVIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXPJR|UxRTRyLkK4Olkh|ryP NGjtTplUSU6JRWK=
ES6 M{\M[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYPJR|UxRTRyLkS1OVIh|ryP NWXhVlJmW0GQR1XS
SNU-387 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NG\HW3VKSzVyPUSwMlgzOzhizszN MVzTRW5ITVJ?
T47D NYfzO2p7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NELmOVJKSzVyPUSxMlAyQTJizszN MkK2V2FPT0WU
G-402 NETwOZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{TIRmlEPTB;NEGuNFgxQSEQvF2= NULIc4VmW0GQR1XS
MZ1-PC MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mo\5TWM2OD12MT64NUDPxE1? MX3TRW5ITVJ?
SW1417 NFu4[nJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4G1UGlEPTB;NEKuN|A{KM7:TR?= Mo\5V2FPT0WU
RERF-LC-MS NYnzV2ptT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV;JdppYUUN3ME20Nk42ODh5IN88US=> MoDyV2FPT0WU
SF539 NWLtZ29vT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3nMfWlEPTB;NEKuOVUzQSEQvF2= MX7TRW5ITVJ?
ESS-1 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NG\PT4JKSzVyPUSzMlU2PThizszN NU\td2JCW0GQR1XS
RO82-W-1 NVzHSJhzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2DwfWlEPTB;NEOuOlE2OyEQvF2= NUDzNpJHW0GQR1XS
S-117 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEHzT3dKSzVyPUSzMlY6PThizszN NFrPNGpUSU6JRWK=
SW756 Mk\PS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoHnTWM2OD12Mz64NlQzKM7:TR?= NXPLfFZZW0GQR1XS
CP66-MEL MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHzv[GVKSzVyPUS1MlcyPDNizszN NE\YWopUSU6JRWK=
H-EMC-SS NEfQbpZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYPJR|UxRTR3Lke2PVMh|ryP MnXRV2FPT0WU
NCI-H2052 NWraT5g3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUjJR|UxRTR3LkmwNlch|ryP NVv4RVdCW0GQR1XS
SW684 M3\DSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYjV[WRFUUN3ME20O{4xODhzIN88US=> Mly1V2FPT0WU
HCC1569 NHXwWppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIDpXo5KSzVyPUS3MlE3PThizszN MVHTRW5ITVJ?
KGN NHPHbYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{\XPGlEPTB;NEeuN|MyOSEQvF2= M{Hob3NCVkeHUh?=
LCLC-103H NIPyNVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUTtbFd3UUN3ME20O{41PDB2IN88US=> Ml3kV2FPT0WU
SW780 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2XFOGlEPTB;NEeuOlM2OSEQvF2= MV\TRW5ITVJ?
NCI-H1703 Mlm5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{nB[2lEPTB;NEiuN|M2OiEQvF2= NEHCbmtUSU6JRWK=
HCC1395 NIPvV2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3zMOmlEPTB;NEiuO|Q{OiEQvF2= M3\rN3NCVkeHUh?=

... Click to View More Cell Line Experimental Data
体内研究 Gefitinib 作用于无胸腺裸鼠，抑制SKOV3 或MDA-MB-231 肿瘤生长。Gefitinib高效作用于两种类型肿瘤。处理14天后，MDA-MB-231肿瘤和SKOV3肿瘤生长抑制分别为71%和32%。

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

细胞实验：[1]
+ 展开
  • Cell lines: NR6, NR6M 和 NR6W 细胞
  • Concentrations: 0 μM -2 μM
  • Incubation Time: 72 小时
  • Method: 呈指数生长的细胞，包括 NR6, NR6M, NR6M和NR6W细胞按6倍接种在96孔板上，每孔为2000个细胞, 粘附，随后在PBS 中清洗，然后在含0.5% FCS的培养基上温育过夜。使用不同浓度(0-2 μM) Gefitinib或溶质对照DMSO 和EGF 处理细胞。诱导NR6wtEGFR和NR6W 细胞增殖的EGF最佳浓度已经测定，因此NR6wtEGFR和 NR6W 细胞中分别加入10 nM和 0.1 nM EGF。NR6 和NR6M细胞中不加入EGF。72 小时后，通过MTT 增殖检测测量细胞数。
    (Only for Reference)
动物实验：[3]
+ 展开
  • Animal Models: 携带 SKOV3或MDA-MB-231肿瘤的无胸腺裸鼠
  • Formulation: 0.2% DMSO
  • Dosages: 75 mg/kg
  • Administration: 饲喂处理
    (Only for Reference)

溶解度 (25°C)

体外 DMSO 89 mg/mL (199.14 mM)
Ethanol 4 mg/mL (8.95 mM)
Water Insoluble
体内 从左到右依次将纯溶剂加入产品，现配现用(数据来自Selleck实验检测而非文献)：
1% CMC Na 		30mg/mL

* 溶解度检测是由Selleck技术部门检测的，可能会和文献中提供的溶解度有所差异，这是由于生产工艺和批次不同产生的正常现象。请按照顺序依次加入各个纯溶剂。

化学数据

分子量 446.90
化学式

C22H24ClFN4O3
CAS号 184475-35-2
稳定性 powder
in solvent
别名 N/A

计算器

摩尔浓度计算器

摩尔浓度计算器

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系，公式为:

质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)

摩尔浓度计算公式

  • 质量
    浓度
    体积
    分子量

*在配置溶液时，请务必参考Selleck产品标签上、MSDS / COA（可在Selleck的产品页面获得）批次特异的分子量使用本工具。

稀释计算器

稀释计算器

用本工具协助配置特定浓度的溶液，使用的计算公式为：

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为: C1V1 = C2V2 ( 输入 输出 )

  • C1
    V1
    C2
    V2

在配置溶液时，请务必参考Selleck产品标签上、MSDS / COA（可在Selleck的产品页面获得）批次特异的分子量使用本工具。.

连续稀释计算器方程

  • 连续稀释

  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
分子量计算器

分子量计算器

通过输入化合物的化学式来计算其分子量：

总分子量：g/mol

注：化学分子式大小写敏感。C10H16N2O2 c10h16n2o2

摩尔浓度计算器

质量 浓度 体积 分子量
计算

临床试验信息

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT03720873 Recruiting EGFR Gene Mutation Fujian Cancer Hospital October 2018 Phase 2
NCT03599518 Recruiting Non Small Cell Lung Cancer Daiichi Sankyo Co. Ltd.|Daiichi Sankyo Inc. October 10 2018 Phase 1
NCT03653546 Not yet recruiting Non-small Cell Lung Cancer|EGFR Gene Mutation|Brain Metastases Alpha Biopharma (Jiangsu) Co. Ltd. August 31 2018 Phase 2|Phase 3
NCT03602027 Not yet recruiting Non-squamous Non-small Cell Lung Cancer Second Affiliated Hospital of Nanchang University August 1 2018 Not Applicable
NCT03656393 Recruiting NSCLC|EGFR Shenzhen People''s Hospital August 31 2018 Phase 3
NCT03529084 Withdrawn Carcinoma Non-small Cell Lung Novartis Pharmaceuticals|Novartis July 23 2018 Phase 3

技术支持

在订购、运输、储存和使用我们的产品的任何阶段，您遇到的任何问题，均可以通过拨打我们的热线电话400-668-6834，或者技术支持邮箱tech@selleck.cn，直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题，请给我们留言。

  • * 必填项

常见问题及建议解决方法

  • 问题 1：

    I try to dissolve Gefitinib (ZD1839) in 0.5% methylcellulose+0.2% Tween 80 for in vivo experiments. However, when I prepare the mixture, it forms precipitates. Exists another way to dissolve completely the compound?

  • 回答：

    S1025 can be dissovled in both 5% DMSO+corn oil and 5% DMSO+30% PEG 300+5% Tween 80+ddH2O at 2.5 mg/ml clearly. It dissolves in DMSO not readily, please sonicate and warm it in water bath at about 45 degree, and dissolve it clearly first. Then add other solvent.

Selleck产品目录册

EGFR Signaling Pathway Map

EGFR Inhibitors with Unique Features

  • 泛EGFR抑制剂

    AZD8931 (Sapitinib) : Pan-ErbB inhibitor, EGFR/ErbB2/ErbB3, IC50=4 nM/3 nM/4 nM.

  • 活性最高的EGFR抑制剂

    Afatinib (BIBW2992) : EGFR(wt), IC50=0.5 nM; EGFR(L858R), IC50=0.4 nM; EGFR(L858R/T790M), IC50=10 nM; HER2, IC50=14 nM.

  • FDA批准的EGFR抑制剂

    Lapatinib : Approved by FDA for breast cancer.

  • 最新的EGFR抑制剂

    CO-1686 (AVL-301) New : Irreversible, mutant-selective EGFR inhibitor with Ki of 21.5 nM and 303.3 nM for EGFRL858R/T790M and EGFRWT, respectively.

相关EGFR产品

  • Erlotinib New

    Erlotinib 是一种EGFR抑制剂，IC50 为 2 nM，对EGFR的敏感性比对人c-Src 或 v-Ab高1000多倍。

  • Afatinib (BIBW2992) Dimaleate New

    Afatinib (BIBW2992) Dimaleate 不可逆地抑制 EGFR/HER2，包括 EGFR(wt)，EGFR(L858R)，EGFR(L858R/T790M) 和 HER2，IC50 分别为0.5 nM，0.4 nM，10 nM 和 14 nM；活性比对Gefitinib抵抗型L858R-T790M EGFR突变体高100倍。

  • Poziotinib (HM781-36B) New

    Poziotinib (HM781-36B)是一种不可逆的泛-HER抑制剂，对HER1，HER2，和HER4的IC50分别为3.2 nM，5.3 nM和23.5 nM。

  • Erlotinib HCl (OSI-744)

    Erlotinib HCl (OSI-744)是一种EGFR抑制剂，在无细胞试验中IC50为2 nM，对EGFR的选择性比对人c-Src或v-Abl高1000多倍。

  • Afatinib (BIBW2992)

    Afatinib (BIBW2992)不可逆地抑制EGFR/ErbB，包括EGFR(wt)，EGFR(L858R)，EGFR(L858R/T790M)，ErbB2（HER2）和ErbB4（HER4），在无细胞试验中IC50分别为0.5 nM，0.4 nM，10 nM，14 nM和1 nM。

  • Osimertinib (AZD9291)

    AZD9291 是口服不可逆的，突变选择性EGFR抑制剂，在 LoVo细胞中对Exon 19 缺失的 EGFR，L858R/T790M EGFR，和 WT EGFR的IC50分别为12.92，11.44 和 493.8 nM。Phase 3。

  • Lapatinib

    Lapatinib，以 Lapatinib Ditosylate的形式使用，是一种有效的EGFR和ErbB2抑制剂，在无细胞试验中IC50分别为10.2和9.8 nM。

    Features:Lapatinib 已经批准用于治疗HER-2阳性转移性乳腺癌。[2]

  • AG-490 (Tyrphostin B42)

    AG-490 (Tyrphostin B42)是一种EGFR抑制剂，在无细胞试验中IC50为0.1 μM，作用于EGFR比作用于ErbB2选择性高135倍，对JAK2也有抑制作用，对Lck，Lyn，Btk，Syk和Src没有抑制活性。

  • Rociletinib (CO-1686, AVL-301)

    Rociletinib (CO-1686, AVL-301)是一种不可逆的，选择性抑制突变型EGFR，在无细胞试验中作用于EGFRL858R/T790M和EGFRWT， Ki分别为21.5 nM和303.3 nM。Phase 2。

  • AG-1478 (Tyrphostin AG-1478)

    AG-1478 (Tyrphostin AG-1478)是一种选择性EGFR抑制剂，在无细胞试验中IC50为3 nM，对HER2-Neu，PDGFR，Trk，Bcr-Abl和InsR几乎没有作用活性。

Tags: 购买Gefitinib (ZD1839) | Gefitinib (ZD1839)供应商 | 采购Gefitinib (ZD1839) | Gefitinib (ZD1839)价格 | Gefitinib (ZD1839)生产 | 订购Gefitinib (ZD1839) | Gefitinib (ZD1839)代理商
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID